Phreesia (PHR) 10-Q 9 Dec 20 2021 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Oct. 31, 2020	Dec. 04, 2020
Entity Addresses [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 31, 2020
Document Transition Report	false
Entity File Number	001-38977
Entity Registrant Name	PHREESIA, INC.
Amendment Flag	false
Entity Central Index Key	0001412408
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--01-31
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	20-2275479
Entity Address, Address Line One	434 Fayetteville St
Entity Address, Address Line Two	Suite 1400
Entity Address, City or Town	Raleigh
Entity Address, State or Province	NC
Entity Address, Postal Zip Code	27601
City Area Code	888
Local Phone Number	654-7473
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	PHR
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		44,162,852
Former Address
Entity Addresses [Line Items]
Entity Address, Address Line One	432 Park Ave. S.
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10016

Balance Sheets

Balance Sheets - USD ($) $ in Thousands		Oct. 31, 2020	Jan. 31, 2020
Current:
Cash and cash equivalents		$ 254,118	$ 90,315
Settlement assets		12,267	12,368
Accounts receivable, net of allowances		27,594	21,978
Deferred contract acquisition costs		1,708	1,720
Prepaid expenses and other current assets		6,825	5,157
Total current assets		302,512	131,538
Property and equipment, net of accumulated depreciation and amortization of $42,665 and $35,551		19,160	14,487
Capitalized internal-use software, net of accumulated amortization of $23,907 and $19,554		9,986	8,735
Operating lease right-of-use assets	[1]	3,192	0
Deferred contract acquisition costs		1,227	1,594
Intangible assets, net of accumulated amortization of $450 and $271		1,020	1,199
Deferred tax asset		496	775
Goodwill		250	250
Other assets		207	180
Total assets		338,050	158,758
Current:
Settlement obligations		12,267	12,368
Current portion of debt and finance lease liabilities		4,722	2,324
Current portion of operating lease liabilities	[1]	1,288	0
Accounts payable		4,215	6,017
Accrued expenses		12,662	9,243
Deferred revenue		6,623	5,401
Total current liabilities		41,777	35,353
Long term debt and finance lease liabilities		24,439	21,540
Operating lease liabilities, noncurrent	[1]	2,158	0
Total liabilities		68,374	56,893
Commitments and contingencies (Note 12)
Stockholders’ Equity:
Common stock, $0.01 par value - 500,000,000 shares authorized as of October 31, 2020 and January 31, 2020, respectively; 44,039,563 and 36,610,763 shares issued and outstanding as of October 31, 2020 and January 31, 2020, respectively		440	366
Additional paid-in capital		573,786	386,383
Accumulated deficit		(303,681)	(284,485)
Treasury stock		(869)	(399)
Total Stockholders’ Equity		269,676	101,865
Total Liabilities and Stockholders’ Equity		$ 338,050	$ 158,758
[1]	Figures as of October 31, 2020 reflect the Company's February 1, 2020 adoption of Accounting Standards Codification No. 842, Leases (ASC 842) . For additional details, see Note 3(c), "Summary of significant accounting policies — Impact of recently adopted accounting pronouncements."

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Oct. 31, 2020	Jan. 31, 2020
Statement of Financial Position [Abstract]
Accumulated depreciation and amortization, property and equipment	$ 42,665	$ 35,551
Accumulated amortization, capitalized internal-use software	23,907	19,554
Accumulated amortization, intangible assets	$ 450	$ 271
Common stock, par value per share (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	500,000,000	500,000,000
Common stock, shares issued (in shares)	44,039,563	36,610,763
Common stock, shares outstanding (in shares)	44,039,563	36,610,763

Unaudited Statements of Operati

Unaudited Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Oct. 31, 2019	Oct. 31, 2020	Oct. 31, 2019
Revenue:
Revenues	$ 38,464,000	$ 32,843,000	$ 106,869,000	$ 91,968,000
Expenses:
Cost of revenue (excluding depreciation and amortization)	6,472,000	4,388,000	16,477,000	12,594,000
Payment processing expense	7,530,000	6,902,000	21,125,000	20,952,000
Sales and marketing	10,481,000	8,348,000	30,013,000	24,170,000
Research and development	5,732,000	4,774,000	16,267,000	13,762,000
General and administrative	10,370,000	7,184,000	28,721,000	20,849,000
Depreciation	2,447,000	2,153,000	7,125,000	6,444,000
Amortization	1,546,000	1,325,000	4,531,000	3,823,000
Total expenses	44,578,000	35,074,000	124,259,000	102,594,000
Operating loss	(6,114,000)	(2,231,000)	(17,390,000)	(10,626,000)
Other income (expense)	62,000	77,000	(229,000)	(740,000)
Change in fair value of warrant liability	0	0	0	(3,307,000)
Interest income (expense)	(467,000)	(219,000)	(1,206,000)	(1,769,000)
Total other income (expense)	(405,000)	(142,000)	(1,435,000)	(5,816,000)
Loss before provision for income taxes	(6,519,000)	(2,373,000)	(18,825,000)	(16,442,000)
Provision for income taxes	(194,000)	(64,000)	(371,000)	(183,000)
Net loss	(6,713,000)	(2,437,000)	(19,196,000)	(16,625,000)
Preferred stock dividend paid	0	0	0	(14,955,000)
Accretion of redeemable preferred stock	0	0	0	(56,175,000)
Net loss attributable to common stockholders, basic and diluted	$ (6,713,000)	$ (2,437,000)	$ (19,196,000)	$ (87,755,000)
Net loss per share attributable to common stockholders, basic and diluted (in dollars per share)	$ (0.17)	$ (0.07)	$ (0.51)	$ (5.85)
Weighted-average common shares outstanding, basic and diluted (in shares)	38,511,370	35,790,951	37,855,503	15,007,247
Subscription and related services
Revenue:
Revenues	$ 17,468,000	$ 14,606,000	$ 50,196,000	$ 41,292,000
Payment processing fees
Revenue:
Revenues	12,917,000	11,559,000	36,452,000	34,781,000
Life sciences
Revenue:
Revenues	$ 8,079,000	$ 6,678,000	$ 20,221,000	$ 15,895,000

Unaudited statements of redeema

Unaudited statements of redeemable preferred stock and stockholders' equity (deficit) - USD ($) $ in Thousands	Total	Common Stock	APIC	Accumulated Deficit	Treasury stock	Series A	Series B	Junior Preferred	Redeemable Preferred
Beginning balance, redeemable preferred stock (in shares) at Jan. 31, 2019						13,674,365	9,197,142	32,746,041	42,560,530
Beginning balance, redeemable preferred stock at Jan. 31, 2019	$ 206,490					$ 79,311	$ 51,872	$ 32,746	$ 42,561
Redeemable Preferred Stock
Accretion of redeemable preferred stock	7,863					$ 5,196	$ 2,667
Ending balance, redeemable preferred stock (in shares) at Apr. 30, 2019						13,674,365	9,197,142	32,746,041	42,560,530
Ending balance, redeemable preferred stock at Apr. 30, 2019	214,353					$ 84,507	$ 54,539	$ 32,746	$ 42,561
Beginning balance (in shares) at Jan. 31, 2019		1,994,721
Beginning balance at Jan. 31, 2019	(210,974)	$ 20	$ 0	$ (210,994)	$ 0
Stockholders' Equity (Deficit)
Net loss	(6,695)			(6,695)
Stock-based compensation expense	599		599
Exercise of stock options and vesting of restricted stock (in shares)		29,798
Exercise of stock options and vesting of restricted stock units	37	$ 0	37
Issuance of common stock warrants	833		833
Accretion of redeemable preferred stock	(7,863)		(1,469)	(6,394)
Ending balance (in shares) at Apr. 30, 2019		2,024,519
Ending balance at Apr. 30, 2019	(224,063)	$ 20	0	(224,083)	0
Beginning balance, redeemable preferred stock (in shares) at Jan. 31, 2019						13,674,365	9,197,142	32,746,041	42,560,530
Beginning balance, redeemable preferred stock at Jan. 31, 2019	206,490					$ 79,311	$ 51,872	$ 32,746	$ 42,561
Ending balance, redeemable preferred stock (in shares) at Oct. 31, 2019						0	0	0	0
Ending balance, redeemable preferred stock at Oct. 31, 2019	0					$ 0	$ 0	$ 0	$ 0
Beginning balance (in shares) at Jan. 31, 2019		1,994,721
Beginning balance at Jan. 31, 2019	(210,974)	$ 20	0	(210,994)	0
Stockholders' Equity (Deficit)
Net loss	(16,625)
Ending balance (in shares) at Oct. 31, 2019		35,872,057
Ending balance at Oct. 31, 2019	102,494	$ 359	382,951	(280,817)	0
Beginning balance, redeemable preferred stock (in shares) at Apr. 30, 2019						13,674,365	9,197,142	32,746,041	42,560,530
Beginning balance, redeemable preferred stock at Apr. 30, 2019	214,353					$ 84,507	$ 54,539	$ 32,746	$ 42,561
Redeemable Preferred Stock
Accretion of redeemable preferred stock	48,312					$ 27,510	$ 20,802
Conversion of preferred stock into common stock and cancellation of redeemable preferred stock (in shares)						(13,674,365)	(9,197,142)	(32,746,041)	(42,560,530)
Conversion of preferred stock into common stock and cancellation of redeemable preferred stock	(262,665)					$ (112,017)	$ (75,341)	$ (32,746)	$ (42,561)
Ending balance, redeemable preferred stock (in shares) at Jul. 31, 2019						0	0	0	0
Ending balance, redeemable preferred stock at Jul. 31, 2019	0					$ 0	$ 0	$ 0	$ 0
Beginning balance (in shares) at Apr. 30, 2019		2,024,519
Beginning balance at Apr. 30, 2019	(224,063)	$ 20	0	(224,083)	0
Stockholders' Equity (Deficit)
Net loss	(7,493)			(7,493)
Stock-based compensation expense	1,467		1,467
Exercise of stock options and vesting of restricted stock (in shares)		22,038
Exercise of stock options and vesting of restricted stock units	41	$ 0	41
Accretion of redeemable preferred stock	(48,312)		(1,508)	(46,804)
Payment of preferred stock dividends	(14,955)		(14,955)
Issuance of common stock in public offering, net of issuance costs (in shares)		7,812,500
Issuance of common stock in public offering, net of issuance costs	124,698	$ 78	124,619
Conversion of preferred stock into common stock and cancellation of redeemable preferred stock (in shares)		25,311,535
Conversion of preferred stock into common stock and cancellation of redeemable preferred stock	262,665	$ 253	262,412
Conversion and exercise of preferred stock warrants into common stock (shares)		588,763
Conversion and exercise of preferred stock warrants into common stock	8,805	$ 6	8,799
Deferred offering costs	(6,084)
Ending balance (in shares) at Jul. 31, 2019		35,759,355
Ending balance at Jul. 31, 2019	102,853	$ 357	380,875	(278,380)	0
Ending balance, redeemable preferred stock (in shares) at Oct. 31, 2019						0	0	0	0
Ending balance, redeemable preferred stock at Oct. 31, 2019	0					$ 0	$ 0	$ 0	$ 0
Stockholders' Equity (Deficit)
Net loss	(2,437)			(2,437)
Stock-based compensation expense	1,766		1,766
Exercise of stock options and vesting of restricted stock (in shares)		59,679
Exercise of stock options and vesting of restricted stock units	366	$ 1	365
Cashless exercise of common stock warrants (in shares)		53,023
Cashless exercise of common stock warrants	2	$ 1	1
Deferred offering costs	(56)		(56)
Ending balance (in shares) at Oct. 31, 2019		35,872,057
Ending balance at Oct. 31, 2019	102,494	$ 359	382,951	(280,817)	0
Beginning balance (in shares) at Jan. 31, 2020		36,610,763
Beginning balance at Jan. 31, 2020	101,865	$ 366	386,383	(284,485)	(399)
Stockholders' Equity (Deficit)
Net loss	(6,112)			(6,112)
Stock-based compensation expense	2,872		2,872
Exercise of stock options and vesting of restricted stock (in shares)		988,678
Exercise of stock options and vesting of restricted stock units	1,737	$ 10	1,727
Treasury stock from vesting of restricted stock units	(447)				(447)
Ending balance (in shares) at Apr. 30, 2020		37,599,441
Ending balance at Apr. 30, 2020	99,915	$ 376	390,982	(290,597)	(846)
Beginning balance (in shares) at Jan. 31, 2020		36,610,763
Beginning balance at Jan. 31, 2020	101,865	$ 366	386,383	(284,485)	(399)
Stockholders' Equity (Deficit)
Net loss	$ (19,196)
Exercise of stock options and vesting of restricted stock (in shares)	1,610,207
Ending balance (in shares) at Oct. 31, 2020		44,039,563
Ending balance at Oct. 31, 2020	$ 269,676	$ 440	573,786	(303,681)	(869)
Beginning balance (in shares) at Apr. 30, 2020		37,599,441
Beginning balance at Apr. 30, 2020	99,915	$ 376	390,982	(290,597)	(846)
Stockholders' Equity (Deficit)
Net loss	(6,371)			(6,371)
Stock-based compensation expense	3,428		3,428
Exercise of stock options and vesting of restricted stock (in shares)		283,396
Exercise of stock options and vesting of restricted stock units	738	$ 3	735
Treasury stock from vesting of restricted stock units	(23)				(23)
Ending balance (in shares) at Jul. 31, 2020		37,882,837
Ending balance at Jul. 31, 2020	97,687	$ 379	395,145	(296,968)	(869)
Stockholders' Equity (Deficit)
Net loss	(6,713)			(6,713)
Stock-based compensation expense	3,316		3,316
Exercise of stock options and vesting of restricted stock (in shares)		406,726
Exercise of stock options and vesting of restricted stock units	876	$ 4	872
Issuance of common stock in public offering, net of issuance costs (in shares)		5,750,000
Issuance of common stock in public offering, net of issuance costs	174,510	$ 57	174,453
Deferred offering costs	(290)
Ending balance (in shares) at Oct. 31, 2020		44,039,563
Ending balance at Oct. 31, 2020	$ 269,676	$ 440	$ 573,786	$ (303,681)	$ (869)

Unaudited statements of redee_2

Unaudited statements of redeemable preferred stock and stockholders' equity (deficit) (Parenthetical) - USD ($) $ in Thousands	Oct. 23, 2020	Oct. 31, 2020	Oct. 31, 2019	Jul. 31, 2019
Statement of Stockholders' Equity [Abstract]
Issuance of common stock, issuance costs	$ 290	$ 290	$ 56	$ 6,084

Unaudited statements of cash fl

Unaudited statements of cash flows - USD ($) $ in Thousands		9 Months Ended
		Oct. 31, 2020	Oct. 31, 2019
Cash flows from operating activities:
Net loss		$ (19,196)	$ (16,625)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		11,656	10,267
Stock-based compensation expense		9,616	3,832
Change in fair value of warrants liability		0	3,307
Amortization of debt discount		318	412
Loss on extinguishment of debt		0	1,073
Cost of hardware purchased by customers		604	512
Deferred contract acquisition costs amortization		2,280	1,465
Non-cash operating lease expense		1,228	0
Deferred tax asset		279	0
Changes in operating assets and liabilities
Accounts receivable		(5,616)	(3,899)
Prepaid expenses and other assets		(1,940)	(2,943)
Deferred contract acquisition costs		(1,901)	(1,414)
Accounts payable		(2,300)	1,629
Accrued expenses and other liabilities		3,982	3,098
Lease liability		(1,419)	0
Deferred revenue		1,222	(1,162)
Net cash used in operating activities		(1,187)	(448)
Cash used in investing activities:
Capitalized internal-use software		(4,663)	(4,329)
Purchase of property and equipment		(6,440)	(4,826)
Net cash used in investing activities		(11,103)	(9,155)
Cash provided by financing activities:
Proceeds from issuance of common stock in equity offerings, net of underwriters' discounts and commissions		174,800	130,781
Payment of preferred stock dividends		0	(14,955)
Proceeds from issuance of common stock upon exercise of stock options		3,351	445
Treasury stock to recover tax withholdings on stock compensation awards		(869)	0
Payment of offering costs		(226)	(5,944)
Proceeds from revolving line of credit		0	9,876
Payments of revolving line of credit		0	(17,676)
Proceeds from term loan		0	20,000
Repayment of term loan and loan payable		0	(21,042)
Insurance financing arrangement		2,009	0
Principal portion of finance lease payments		(1,797)	(1,624)
Principal payments on financing arrangements		(881)	0
Debt extinguishment costs		0	(300)
Debt issuance costs		(69)	(112)
Loan facility fee payment		(225)	0
Net cash provided by financing activities		176,093	99,449
Net increase in cash and cash equivalents		163,803	89,846
Cash and cash equivalents – beginning of period		90,315	1,543
Cash and cash equivalents – end of period		254,118	91,389
Supplemental information of non-cash investing and financing information:
Right-of-use assets recorded in exchange for lease liabilities	[1]	4,420	0
Property and equipment acquisitions through finance leases		6,050	1,738
Capitalized software acquired through vendor financing		174	0
Purchase of property and equipment and capitalized software included in accounts payable		1,681	546
Issuance of warrants related to debt		0	833
Cashless transfer of term loan and related accrued fees into increase in debt balance		20,257	0
Cashless transfer of lender fees through increase in debt balance		406	0
Deferred offering costs included in accounts payable and accrued liabilities		64	0
Cashless exercise of common stock warrants		0	2,521
Cash payments for:
Interest		$ 1,047	$ 1,834
[1]	Includes $2,741 initial right of use asset recorded upon adoption of ASC 842.

Unaudited statements of cash _2

Unaudited statements of cash flows (Parenthetical) - USD ($) $ in Thousands	Oct. 31, 2020		Feb. 01, 2020	Jan. 31, 2020
Statement of Cash Flows [Abstract]
Lease right-of-use assets	$ 3,192	[1]	$ 2,741	$ 0	[1]
[1]	Figures as of October 31, 2020 reflect the Company's February 1, 2020 adoption of Accounting Standards Codification No. 842, Leases (ASC 842) . For additional details, see Note 3(c), "Summary of significant accounting policies — Impact of recently adopted accounting pronouncements."

Background and liquidity

Background and liquidity	9 Months Ended
	Oct. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Background and liquidity	Background and liquidity (a) Background Phreesia, Inc. (the Company) is a leading provider of comprehensive solutions that transform the healthcare experience by engaging patients in their care and enabling healthcare provider organizations to optimize operational efficiency, improve profitability and enhance clinical care. Through the SaaS-based Phreesia Platform (the Phreesia Platform), the Company offers healthcare provider organizations a robust suite of solutions to manage the patient intake process and a leading payments solution for secure processing of patient payments. The Company’s Platform also provides life sciences companies with an engagement channel for targeted and direct communication with patients. In connection with the patient intake and registration process, Phreesia offers its provider customers the ability to lease tablets (PhreesiaPads) and on-site kiosks (Arrival Stations) along with their monthly subscription. The Company was formed in May 2005, and has offices in New York, New York, Raleigh, North Carolina and Ottawa, Canada. On December 9, 2020, the Company changed its headquarters from New York, New York to Raleigh, North Carolina. (b) Initial public offering On July 22, 2019, the Company closed its initial public offering (IPO), in which the Company issued and sold 7,812,500 shares of common stock at a public offering price of $18.00 per share, resulting in net proceeds of $130,781, after deducting underwriting discounts and commissions of $9,844 but before deducting deferred offering costs of $6,412. In addition to the shares of common stock sold by the Company upon the IPO, certain selling stockholders sold an aggregate of 2,868,923 shares of common stock as part of the IPO. In addition, all then outstanding shares of Convertible Preferred stock converted into 25,311,525 shares of common stock and the Company issued 757,625 shares of common stock as a result of the cashless exercise of warrants as of January 31, 2020. (c) Follow-on offerings On December 17, 2019, the Company closed its follow-on offering of 7,762,500 shares of common stock sold by certain selling stockholders. The Company did not receive any proceeds from the follow-on offering but did incur $1,047 in transaction costs, recorded as general and administrative expense within the statement of operations. On October 23, 2020, the Company closed an additional public offering in which the Company issued and sold 5,750,000 shares of its common stock at a public offering price of $32.00 per share, resulting in net proceeds of $174,510 after deducting underwriting discounts and offering expenses. (d) Liquidity Since the Company commenced operations, it has not generated sufficient revenue to meet its operating expenses and has continued to incur significant net losses. To date, the Company has primarily relied upon the proceeds from issuances of preferred stock and debt, and most recently with proceeds from the follow-on equity offerings, to fund its operations as well as sales of Company products and services in the normal course of business. Management believes that net losses and negative cash flows will continue for at least the next year. Management believes that the Company’s cash and cash equivalents at October 31, 2020, along with cash generated in the normal course of business, and available borrowing capacity under its May 2020 Credit Facility (See Note 6), are sufficient to fund its operations for at least the next 12 months. The Company will obtain additional financing, if needed, to successfully implement its long-term strategy. There can be no assurance that additional financing, if needed, can be obtained on terms acceptable to the Company. The ability of the Company to achieve successful operations will depend on, among other things, new business, the retention of customers, and the effectiveness of sales and marketing initiatives. The Company is subject to a number of risks similar to other companies in its stage of business life cycle, including dependence on key individuals, competition in the marketplace, and the need to fund future product and services development.

Basis of presentation

Basis of presentation	9 Months Ended
	Oct. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of presentation	Basis of presentation (a) Basis of presentation The accompanying financial statements have been prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) and include the accounts of Phreesia, Inc. and its branch operation in Canada. (b) Fiscal year The Company’s fiscal year ends on January 31. References to fiscal 2021 and 2020 refer to the fiscal years ended January 31, 2021 and January 31, 2020, respectively. (c) Unaudited interim financial statements The accompanying unaudited interim financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. In the opinion of management, the accompanying unaudited financial statements reflect all adjustments, which include normal recurring adjustments, necessary for the fair statement of the Company’s interim financial position as of October 31, 2020 and the results of its operations, changes in its stockholders' equity and its cash flows for the periods ended October 31, 2020 and 2019. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. The results for the interim periods are not necessarily indicative of results to be expected for the full year, any other interim periods, or any future year or period. The Company’s management believes that the disclosures herein are adequate to make the information presented not misleading when read in conjunction with the audited financial statements and accompanying notes for the fiscal year ended January 31, 2020. (d) Reclassifications

Summary of significant accounti

Summary of significant accounting policies	9 Months Ended
	Oct. 31, 2020
Accounting Policies [Abstract]
Summary of significant accounting policies	Summary of significant accounting policies The Company’s significant accounting policies are disclosed in the audited financial statements for the fiscal year ended January 31, 2020. Since the date of those audited financial statements, there have been no material changes to the Company’s significant accounting policies, including the status of recent accounting pronouncements, other than those detailed below. (a) Use of estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates and assumptions on historical experience, known trends and events and various other factors that management believes to be reasonable under the circumstances, the results of which form the basis for making judgments. Although management believes its estimates and assumptions are reasonable under the circumstances at the time they are made, they are based upon information available at the time they are made. Management evaluates the estimates and assumptions on an ongoing basis and, if necessary, makes adjustments. Actual results may differ from those estimates made under different assumptions or circumstances. The most significant assumptions and estimates relate to the accounts receivable allowance, capitalized internal-use software, the determination of the useful lives of property and equipment and capitalized software, the fair value of securities underlying stock-based compensation awards issued prior to our initial public offering, the fair value of business acquisitions, and the realization of deferred tax assets. (b) Concentrations of credit risk Financial instruments which potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable and settlement assets. The Company’s cash and cash equivalents are held by established financial institutions. The Company does not require collateral from its customers and generally requires payment within 30 to 60 days of billing. Settlement assets are amounts due from well-established payment processing companies and normally take one or two business days to settle which mitigates the associated risk of concentration. The Company has one third-party payment processor. The Company’s customers are primarily physician’s offices located in the United States and pharmaceutical companies. The Company did not have any individual customers that represented more than 10% of total revenues for the three and nine months ended October 31, 2020 and 2019. As of October 31, 2020, we had receivables from two entities which accounted for 16% and 11%, respectively, of total accounts receivable. (c) Risks Related to the COVID-19 Pandemic In December 2019 and early 2020, an outbreak of a novel strain of coronavirus (COVID-19) occurred. COVID-19 spread to a number of countries including the United States and Canada and was declared a pandemic by the World Health Organization. There continues to be uncertainty as to the extent to which the global COVID-19 pandemic may adversely impact our business operations, financial performance, and results of operations at this time. (c) New accounting pronouncements Impact of recently adopted accounting pronouncements On May 1, 2020, the Company adopted ASU 2018-15, Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract, which is intended to align the requirements for capitalization of implementation costs incurred in a cloud computing arrangement that is a service contract with the existing guidance for internal-use software. The guidance requires capitalized costs to be included within prepaid expenses and the guidance requires amortization of capitalized costs to be included in the same line as the associated cloud subscription costs in the statement of operations. The Company adopted ASU 2018-15 prospectively for implementation costs incurred subsequent to May 1, 2020. See Note 4 - Composition of Certain Financial Statement Captions for additional information. On February 1, 2020, the Company adopted the Financial Accounting Standards Board's (FASB) Accounting Standard Update (ASU) No. 2016-02, Leases (Topic 842) (ASC 842) which requires lessees to record most leases on their balance sheets but to recognize the expenses in their statement of operations in a manner similar to the prior standard. Topic 842 states that a lessee would recognize a lease liability for the obligation to make lease payments and a right-of-use asset for the right to use the underlying asset for the lease term. The Company adopted the new lease guidance using a modified retrospective transition method applied to those leases which were not completed as of February 1, 2020. As a result, the Company was not required to adjust its comparative period financial information for effects of the standard or make the new required lease disclosures for the periods before the date of adoption. The Company elected the ‘package of practical expedients,’ which permits the Company not to reassess under the new standard our prior conclusions about lease identification, lease classification and initial direct costs. The Company did not elect the use-of-hindsight practical expedient. The new standard also provides practical expedients for an entity’s ongoing accounting. The Company elected the short-term lease recognition exemption for all of its leases. This means, for those leases that qualify, the Company will not recognize right-of-use assets or lease liabilities, including existing short-term leases as of the transition date. The Company also elected the practical expedient to not separate lease and non-lease components for its office and computer equipment leases. Upon adoption of Topic 842 the Company recognized operating lease right-of-use assets and operating lease liabilities related to our office leases of $2,741 and $2,928, respectively. The Company’s accounting for lessee finance and all lessor leases remains substantially unchanged from legacy guidance. The standard did not have a significant impact on our statements of operations or statements of cash flows. No adjustment to accumulated deficit was recorded because the adoption did not change the Company's net assets. In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820) : Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement (ASU 2018-13). ASU 2018-13 updates the disclosure requirements for fair value measurements and is effective for financial statements issued for fiscal years beginning after December 15, 2019. The Company adopted the new guidance effective February 1, 2020, and it did not have a material effect on its financial statements. On February 1, 2020, the Company adopted ASU 2016-13, Financial Instruments - Credit Losses . The update requires the recognition of all losses expected over the life of a financial instrument upon origination or purchase of the instrument. The Company adopted this update using a modified retrospective method. No adjustment to accumulated deficit was recorded as a result of the adoption of this standard, which did not have a material impact on the Company's financial statements. Recent accounting pronouncements not yet adopted There are no recently issued accounting pronouncements the Company has not yet adopted that will materially impact the Company's financial statements.

Composition of certain financia

Composition of certain financial statement captions	9 Months Ended
	Oct. 31, 2020
Composition Of Certain Financial Statement [Abstract]
Composition of certain financial statement captions	Composition of certain financial statement captions (a) Accrued expenses Accrued expenses as of October 31, 2020 and January 31, 2020 are as follows: October 31, 2020 January 31, 2020 Payroll-related expenses and taxes $ 7,846 $ 5,032 Payment processing fees liability 2,634 2,738 Other 2,182 1,473 Total $ 12,662 $ 9,243 (b) Property and equipment Property and equipment as of October 31, 2020 and January 31, 2020 are as follows: Useful Life (years) October 31, 2020 January 31, 2020 PhreesiaPads and Arrivals Stations 3 $ 29,857 $ 26,389 Computer equipment 3 25,990 18,394 Computer software 3 3,010 2,297 Hardware development 3 1,024 1,024 Furniture and fixtures 7 743 743 Leasehold improvements 2 1,201 1,191 Total property and equipment $ 61,825 $ 50,038 Less accumulated depreciation and amortization (42,665) (35,551) Property and equipment — net $ 19,160 $ 14,487 Depreciation expense related to property and equipment amounted to $2,447 and $2,153 for the three months ended October 31, 2020 and 2019, respectively. Depreciation expense related to property and equipment amounted to $7,125 and $6,444 for the nine months ended October 31, 2020 and 2019, respectively. Finance lease depreciation, included in depreciation expense, was $2,278 for the nine months ended October 31, 2020. Assets under finance leases included in computer equipment were $17,078 and $12,283 as of October 31, 2020 and January 31, 2020. Accumulated amortization of assets under finance leases was $9,555 and $7,724 as of October 31, 2020 and January 31, 2020, respectively. (c) Capitalized internal use software For the three months ended October 31, 2020 and 2019, the Company capitalized $1,972 and $1,452, respectively, of costs related to the Phreesia Platform. For the nine months ended October 31, 2020 and 2019, the Company capitalized $5,604 and $4,329, respectively, of costs related to the Phreesia Platform. During the three months ended October 31, 2020 and 2019, amortization expense related to capitalized internal-use software was $1,487 and $1,266, respectively. During the nine months ended October 31, 2020 and 2019, amortization expense related to capitalized internal-use software was $4,353 and $3,645, respectively. As of October 31, 2020 and January 31, 2020, the net book value of the Phreesia Platform was $9,986 and $8,735, respectively. (d) Intangible assets and goodwill The following presents the details of intangible assets as of October 31, 2020 and January 31, 2020: Useful Life (years) October 31, 2020 January 31, 2020 Acquired technology 5 $ 490 $ 490 Customer relationship 7 980 980 Total intangible assets, gross carrying value $ 1,470 $ 1,470 Less accumulated amortization (450) (271) Net carrying value $ 1,020 $ 1,199 The remaining useful life for acquired technology in years is 3.1 and 3.9 as of October 31, 2020 and January 31, 2020, respectively. The remaining useful life for customer relationships in years is 5.1 and 5.9 as of October 31, 2020 and January 31, 2020, respectively. Amortization expense associated with intangible assets amounted to $59 and $59 for the three months ended October 31, 2020 and 2019, respectively. Amortization expense associated with intangible assets amounted to $178 and $178 for the nine months ended October 31, 2020 and 2019, respectively. The estimated amortization expense for intangible assets for the next five years and thereafter is as follows as of October 31, 2020: October 31, 2020 2021 (Remaining three months) $ 60 Fiscal Years Ending January 31, 2022 238 2023 238 2024 224 2025 - thereafter 260 Total $ 1,020 There were no changes to the Company's goodwill balance during the nine months ended October 31, 2020. The Company did not record any impairments of goodwill during the three and nine months ended October 31, 2020 or 2019, respectively. Goodwill was $250 as of October 31, 2020 and January 31, 2020. (e) Accounts receivable Accounts receivable as of October 31, 2020 and January 31, 2020 are as follows: October 31, 2020 January 31, 2020 Billed $ 26,000 $ 22,245 Unbilled 2,344 676 Total accounts receivable, gross $ 28,344 $ 22,921 Less accounts receivable allowances (750) (943) Total accounts receivable $ 27,594 $ 21,978 Activity in our allowance for doubtful accounts was as follows for the nine months ended October 31, 2020: October 31, 2020 Balance, January 31, 2020 $ 943 Bad debt expense 396 Write-offs and adjustments (589) Balance, October 31, 2020 $ 750 The Company’s allowance for doubtful accounts represents the current estimate of expected future losses based on prior bad debt experience as well as considerations for specific customers as applicable. The Company's accounts receivable are considered past due when they are outstanding past the due date listed on the invoice to the customer. As of October 31, 2020, 58% of the Company's accounts receivable was aged less than 30 days from the invoice date and 15% of the Company's accounts receivable was aged over 90 days from the invoice date. The Company writes off accounts receivable and removes the associated allowance for doubtful accounts when the Company deems the receivables to be uncollectible. (f) Prepaid and other current assets Prepaid and other current assets as of October 31, 2020 and January 31, 2020 are as follows: October 31, 2020 January 31, 2020 Prepaid software and business systems 1,994 $ 1,611 Prepaid PhreesiaPads 394 645 Prepaid data center expenses 350 751 Prepaid insurance 1,969 1,259 Other prepaid expenses and other current assets 2,118 891 Total prepaid and other current assets $ 6,825 $ 5,157 The Company enters into cloud computing service contracts to support our sales and marketing, product development and administrative activities. Subsequent to the adoption of ASU 2018-15 in May 2020, we capitalize certain implementation costs for cloud computing arrangements that meet the definition of a service contract. We include these capitalized implementation costs within Prepaid software and business systems in the table above. Once placed in service, we amortize these costs over the remaining subscription term to the same expense line as the related cloud subscription. Capitalized implementation costs for cloud computing arrangements accounted for as service contracts were $283 and $434 for the three and nine months ended October 31, 2020. Accumulated amortization of capitalized implementation costs for these arrangements was $13 as of October 31, 2020. (g) Other income (expense) Other income for the three months ended October 31, 2020 and 2019 was $62 and $77, and was composed primarily of foreign exchange gains. Other expense for the nine months ended October 31, 2020 was $229 and was composed primarily of foreign exchange losses. Other expense for the nine months ended October 31, 2019 was $740 and was composed primarily of loss on extinguishment of debt of $1,073, partially offset by foreign exchange gains.

Revenue

Revenue	9 Months Ended
	Oct. 31, 2020
Revenue from Contract with Customer [Abstract]
Revenue	RevenueThe Company generates revenue primarily from providing an integrated SaaS-based software and payment platform for the healthcare industry. The Company derives revenue from subscription fees and related services generated from the Company’s provider customers for access to the Phreesia Platform, payment processing fees based on patient payment volume processed through the Phreesia Platform, and from digital patient engagement revenue from life sciences companies to reach, educate and communicate with patients when they are most receptive and actively seeking care. The amount of subscription and related services revenue recorded pursuant to ASC 842 for the leasing of the Company’s PhreesiaPads and Arrival Stations was $1,593 and $1,496 for the three months ended October 31, 2020 and 2019, respectively. The amount of subscription and related services revenue recorded pursuant to ASC 842 for the leasing of the Company’s PhreesiaPads and Arrival Stations was $4,732 and $4,462 for the nine months ended October 31, 2020 and 2019, respectively. Contract balances The following table represents a roll-forward of contract assets: Contract assets (unbilled accounts receivable) January 31, 2020 $ 676 Amount transferred to receivables from beginning balance of contract assets (676) Contract asset additions, net of reclassification to receivables 2,344 October 31, 2020 $ 2,344 The following table represents a roll-forward of contract liabilities: Contract liabilities (deferred revenue) January 31, 2020 $ 5,401 Revenue recognized that was included in deferred revenue at the beginning of the period (5,004) Revenue recognized that was not included in deferred revenue at the beginning of the period (1,168) Increases due to invoicing prior to satisfaction of performance obligations 7,394 October 31, 2020 $ 6,623 Cost to obtain a contract The Company capitalizes certain incremental costs to obtain customer contracts and amortizes these costs over a period of benefit that the Company has estimated to be three years. The Company determined the period of benefit by taking into consideration its customer contracts, its technology and other factors. Amortization expense is included in sales and marketing expenses in the accompanying statements of operations and totaled $505 and $491 for the three months ended October 31, 2020 and 2019, respectively. Amortization expense totaled $2,280 and $1,465 for the nine months ended October 31, 2020 and 2019, respectively. The Company periodically reviews these deferred contract acquisition costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit. There were no impairment losses recorded during the periods presented. The following table represents a roll forward of deferred contract acquisition costs: Beginning balance, January 31, 2020 $ 3,314 Additions to deferred contract acquisition costs 1,901 Amortization of deferred contract acquisition costs (2,280) Ending balance, October 31, 2020 2,935 Deferred contract acquisition costs, current (to be amortized in next 12 months) 1,708 Deferred contract acquisition costs, non-current 1,227 Total deferred contract acquisition costs $ 2,935

Debt and Finance Lease Liabilit

Debt and Finance Lease Liabilities	9 Months Ended
	Oct. 31, 2020
Debt Disclosure [Abstract]
Debt and Finance Lease Liabilities	Debt and Finance Lease Liabilities As of October 31, 2020 and January 31, 2020, the Company had the following outstanding debt and finance lease liabilities: October 31, 2020 January 31, 2020 Revolving credit facility $ 20,663 $ — Term loan — 20,000 Finance leases 7,607 3,612 Other debt 2,146 808 Accrued interest and payments 65 381 Total debt and finance lease liabilities, before original issue discount 30,481 24,801 Less deferred financing costs and original issue discount (1,320) (937) Debt and finance lease liabilities 29,161 23,864 Less - current portion of debt and finance lease liabilities (4,722) (2,324) Long term debt and finance lease liabilities $ 24,439 $ 21,540 Second Amended and Restated Loan and Security Agreement On May 5, 2020 (the "Second SVB Effective Date"), the Company entered into a Second Amended and Restated Loan and Security Agreement (“the Second SVB Facility”) with Silicon Valley Bank. The Second SVB Facility modified the First Amended and Restated Loan and Security Agreement, dated February 28, 2019 (the "First SVB Facility"). The Second SVB Facility provides for a revolving credit facility with an initial borrowing capacity of $50,000. The borrowing capacity may be increased to $65,000 at the sole discretion of Silicon Valley Bank. Upon entering into the Second SVB Facility, the Company borrowed $20,663 against the revolving credit facility. The Company used the proceeds from its initial revolving credit borrowing to repay all amounts due under the First SVB Facility term loan, including the $20,000 outstanding principal amount plus a prepayment fee of $300 and an accrued final payment fee of $363. Borrowings under the revolving credit facility are payable five years from the Effective Date, which is May 5, 2025 (the "Maturity Date"). Borrowings under the revolving credit facility bear interest, which is payable monthly, at a floating rate equal to the greater of the Wall Street Journal Prime Rate or 4.5%, until such time that adjusted EBITDA as defined in the Second SVB Facility (SVB Facility Adjusted EBITDA) reaches a defined level, after which time the interest rate is reduced to the greater of prime less 0.5%, or 4.0%. For the three months ended October 31, 2020, the interest rate on the Second SVB Facility was 4.5%. In addition to principal and interest due under the revolving credit facility, the Company is required to pay an annual commitment fee of $125 per year. The first facility fee payment of $125 was paid during the three months ended July 31, 2020. The Company has $29,337 of availability as of October 31, 2020. In the event that the Company terminates the Second SVB Facility prior to the Maturity Date, the Company will be required to pay a termination fee equal to (i) $187, reduced by $6 for each calendar month that has elapsed after April 30, 2020, plus (ii) a percent of the total borrowing capacity equal to 1.5% if terminated before the second anniversary of the Second SVB Effective Date, 0.75% if terminated on or after the second and before the third anniversary of the Second SVB Effective Date funding, or 0.5% if terminated on or after the third and before the fourth anniversary of the Second SVB Effective Date. The Company will not be required to pay a termination fee if terminated after the fourth anniversary of the Second SVB Effective Date. The Company’s obligations under the Second SVB Facility are secured by a first priority security interest in substantially all of its assets, other than intellectual property. The Second SVB Facility includes a financial covenant that requires the Company to achieve specified levels of SVB Facility Adjusted EBITDA. The financial covenant will not be effective if the Company maintains certain levels of liquidity as defined. The Company was in compliance with all covenants related to the Second SVB Facility as of October 31, 2020. The Second SVB Facility contains events of default, including, without limitation, events of default upon: (i) failure to make payment pursuant to the terms of the agreement; (ii) violation of covenants; (iii) material adverse changes to the Company’s business; (iv) attachment or levy on the Company’s assets or judicial restraint on its business; (v) insolvency; (vi) significant judgments, orders or decrees for payments by the Company not covered by insurance; (vii) incorrectness of representations and warranties; (viii) incurrence of subordinated debt; (ix) revocation of governmental approvals necessary for the Company to conduct its business; and (x) failure by the Company to maintain a valid and perfected lien on the collateral securing the borrowing. During the three months ended July 31, 2020, the Company accounted for the settlement of the First SVB Facility term loan and the borrowings under the Second SVB Facility as a modification of the First SVB Facility term loan, because the cash flows under the Second SVB Facility were not substantially different than the cash flows under the First SVB Facility term loan. The Company incurred $531 of fees in connection with the Second SVB Facility, including $406 of fees to terminate the First SVB Facility and $125 of fees to enter into the Second SVB Facility. As the Second SVB Facility was accounted for as a modification, the Company recorded these fees as an additional discount on debt. The Company recorded third party costs as additional discount on debt because the unused borrowing capacity on the revolving credit facility contained in the Second SVB Facility was greater than the borrowing capacity on the revolving credit facility in the First SVB Facility. The Company is continuing to amortize the existing and newly recorded discount on debt using the effective interest method. First Amended and Restated Loan and Security Agreement On February 28, 2019 (the Effective Date), the Company entered into a First Amended and Restated Loan and Security Agreement (the "First SVB Facility") that provided for a $20,000 term loan (the "2019 Term Loan"). Interest on the term loan was payable monthly, at a floating rate equal to the bank’s prime rate plus 1.50%, subject to reduction based on achievement of defined EBITDA levels. The Company recorded $257 of interest expense for a final payment during the three months ended October 31, 2019. In connection with the First SVB Facility, the Company issued warrants to the lenders to purchase an aggregate of 150,274 shares of common stock at an exercise price of $8.02 per share. The 75,137 common stock warrants that remain outstanding as of October 31, 2020 expire in February 2029. Borrowings under the prior term loan and loans payable were repaid in full with the proceeds from the First SVB Facility. The First SVB Facility also contained a revolving credit facility with $25,000 of available borrowings. As of January 31, 2020 and as of the date of the Second SVB Facility, the Company had no borrowings outstanding under the revolving credit facility. The Company paid $100 of facility fees during the three months ended October 31, 2020 and 2019, respectively. Upon entering into the First SVB Facility, during the nine months ended October 31, 2019, the Company recorded a $1,073 loss on extinguishment of debt within other income (expense) for the settlement of the previously outstanding loans payable. Finance Leases See Note 11 - Leases for more information regarding finance leases. Other Debt (Financing Agreements) On July 21, 2020, the Company entered into an insurance premium financing agreement with IPFS of New York LLC in order to finance its premium payments for Directors' and Officers' insurance. As of October 31, 2020, the outstanding principal amount under the agreement is $1,341. The agreement bears interest of 2.6% per annum. Principal and interest are due in two equal installments of $677, payable in December 2020 and March 2021. The total interest remaining to be paid under the arrangement is $13. On April 10, 2020, the Company entered into a vendor financing agreement with a principal amount of $174 to finance the acquisition of certain internal use software licenses. As of October 31, 2020, the outstanding principal balance of the financing agreement is $132. Interest accrues at an annual rate of 2.94%. The Company is required to make equal annual payments of $46 on May 31, 2021, May 31, 2022 and May 31, 2023. On November 2, 2018, the Company entered into a vendor financing agreement with a principal amount of $1,256 to finance the acquisition of certain internal use software licenses. As of October 31, 2020, the outstanding principal balance of the financing agreement is $673. Interest accrues at an annual rate of 9.83%. The Company is required to pay four equal payments of $183 in November 2020, May 2021, November 2021 and June 2022. Maturities of debt, including finance leases, in each of the next five years and thereafter are as follows: Total Debt Finance Leases Fiscal 2021 (remaining three months) $ 1,509 $ 845 $ 664 Fiscal year ending January 31: 2022 4,050 1,077 2,973 2023 2,442 184 2,258 2024 1,290 40 1,250 2025 21,190 20,728 462 Total long-term debt and finance lease maturities $ 30,481 $ 22,874 $ 7,607 During the three and nine months ended October 31, 2020, the Company recorded net interest expense of $467 and $1,206, respectively, including amortization of original issue discount and deferred financing costs of $74 and $318, respectively. For the three months ended October 31, 2020, net interest expense included interest expense of $471, net of interest income of $5. For the nine months ended October 31, 2020, net interest expense included interest expense of $1,305, net of interest income of $99. During the three and nine months ended October 31, 2019, the Company recorded net interest expense of $219 and $1,769, respectively, including amortization of original issue discount and deferred financing costs of $147 and $412, respectively For the three months ended October 31, 2019, net interest expense included interest expense of $557, net of interest income of $338. For the nine months ended October 31, 2019, net interest expense included interest expense of $2,142, net of interest income of $373.

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Oct. 31, 2020
Equity [Abstract]
Stockholders' Equity	Stockholders' Equity (a) Common stock The Company closed an IPO on July 22, 2019 and filed an Amended and Restated Certificate of Incorporation authorizing the issuance of up to 500,000,000 shares of common stock, par value $0.01 per share. On October 23, 2020, the Company completed a follow-on offering of its Common Stock. In connection with the follow-on offering, the Company issued and sold 5,750,000 shares of common stock at an issuance price of $32.00 per share resulting in net proceeds of $174,800, after deducting underwriting discounts and commissions. The Company also incurred $290 of net third party offering costs. (b) Preferred stock In connection with the IPO, the Company's Amended and Restated Certificate of Incorporation also authorized 20,000,000 shares of undesignated preferred stock with a value of $0.01 per share. As of October 31, 2020 and January 31, 2020, no shares of this preferred stock were issued and outstanding. (c) Treasury stock The Company's equity based compensation plan allows for the grant of non-vested stock options, restricted stock units (RSUs), and performance-based RSUs to its employees pursuant to the terms of its stock option and incentive plans (See Note 8). Under the provision of the plans, for RSU awards, unless otherwise elected, participants fulfill their related income tax withholding obligation by having shares withheld at the time of vesting. On the date of vesting of the RSU, the Company divides the participant's income tax obligation in dollars by the closing price of its common stock and withholds the resulting number of vested shares. The shares withheld are then transferred to the Company's treasury stock at cost.

Equity-based compensation

Equity-based compensation	9 Months Ended
	Oct. 31, 2020
Share-based Payment Arrangement [Abstract]
Equity-based compensation	Equity-based compensation(a) Equity Award Plans In 2006, the Board of Directors adopted the Company’s 2006 Stock Option Plan, which, as amended, provided for the issuance of options to purchase up to 4,424,986 shares of the Company’s common stock to officers, directors, employees, and consultants. The 2006 Stock Option Plan expired in August 2017. In January 2018, the Board of Directors adopted the Company’s 2018 Stock Option Plan (as amended), which currently provides for the issuance of options to purchase up to 3,048,490 shares of the Company’s common stock to officers, directors, employees, and consultants. The option exercise price per share is determined by the Board of Directors based on the estimated fair value of the Company’s common stock. In June 2019, the Board of Directors adopted the Company’s 2019 Stock Option and Incentive Plan, which replaced the 2018 Stock Option Plan upon the completion of the IPO. The 2019 Plan allows the Compensation Committee to make equity-based incentive awards including stock options and restricted stock units (RSUs) to the Company’s officers, employees, directors, and consultants. The initial reserve for the issuance of awards under this Plan was 2,139,683 shares of common stock. The initial number of shares reserved and available for issuance automatically increased on February 1, 2020 and will automatically increase each February 1 thereafter by 5% of the number of shares of common stock outstanding on the immediately preceding January 31 (or such lesser number of shares determined by the Compensation Committee). ( b) Stock Options Options granted under the plans have a maximum term of ten years and vest over a period determined by the Board of Directors (generally four years from the date of grant or the commencement of the grantee’s employment with the Company). Options generally vest 25% at the one-year anniversary of the grant date, after which point they generally vest pro rata on a monthly basis. Effective July 2019, all available shares from expired, terminated, or forfeited awards that remained under the 2006 or 2018 prior stock compensation plans were made available for grant under the 2019 Plan. In June 2019, the Board of Directors also adopted the Company’s 2019 Employee Stock Purchase Plan (The ESPP), which became effective immediately prior to the effectiveness of the registration statement for the Company’s initial public offering. The total shares of common stock initially reserved under the ESPP is limited to 855,873 shares. Stock option activity for the nine months ended October 31, 2020 is as follows: Number of Weighted- Weighted- Aggregate Intrinsic Outstanding — January 31, 2020 5,516,452 $ 3.80 Granted in nine months ended October 31, 2020 — $ — Exercised (1,610,207) $ 2.08 Forfeited and expired (54,083) $ 7.31 Outstanding and expected to vest — October 31, 2020 3,852,162 $ 4.46 6.03 $ 125,217 Exercisable — October 31, 2020 2,625,365 $ 3.12 5.09 $ 88,856 Amount vested in nine months ended October 31, 2020 476,680 $ 5.52 As of October 31, 2020, there are 4,181,522 shares available for future grant pursuant to the 2019 Plan after factoring in the automatic increase from February 1, 2020, as well as an additional 855,873 shares available for future grant pursuant to the ESPP. The aggregate intrinsic value represents the total pre-tax intrinsic value (the difference between the Company’s estimated stock price at the time of exercise and the exercise price, multiplied by the number of related in-the-money options) that would have been received by the option holders had they exercised their options at the end of the period. This amount changes based on the market value of the Company’s common stock. The total intrinsic value of options exercised for the nine months ended October 31, 2020 and 2019 (based on the difference between the Company’s estimated stock price on the exercise date and the respective exercise price, multiplied by the number of options exercised), was $52,537 and $1,728, respectively. For the three months ended October 31, 2020 and 2019, the Company recorded stock-based compensation expense for stock options of $632 and $809, respectively. For the nine months ended October 31, 2020 and 2019, the Company recorded stock-based compensation expense for stock options of $2,111 and $2,051, respectively. As of October 31, 2020, there is $4,078 of total unrecognized compensation cost related to stock options issued to employees that is expected to be recognized over a weighted-average term of 2.06 years. For the three and nine months ended October 31, 2020, stock-based compensation expense for stock options includes $88 and $312, respectively, related to the modification of stock options. The Company has not recognized and does not expect to recognize in the foreseeable future, any tax benefit related to employee stock-based compensation expense. (c) Restricted stock units During fiscal 2020, prior to the IPO, the Company issued stock units to employees and directors that vest based on both a time-based condition and a performance-based condition. Pursuant to the time-based condition, 10% of the restricted stock units vest after one year, 20% vest after two years, 30% vest after three years and 40% vest after four years. The performance-based condition was based on a sale of the Company or an IPO, as defined. The restricted stock units expire seven years from the grant date. Upon completion of the Company’s IPO in July 2019, the Company immediately recognized the fair value of the vested units with the unvested portion recognized over the remaining service period. In addition, in August 2019, the Company approved allowing executive officers the ability to elect to receive all or a portion of the bonus (based on its target bonus opportunity for the last half of the fiscal year) in the form of restricted stock units instead of cash. For such executive officers that elected to receive restricted stock units, such award was granted immediately after such election with a value equal to the portion of the target bonus opportunity that the executive officer elected not to receive in cash, and such award vests based on the achievement of the Company’s pre-defined performance targets. These performance-based awards were released in April 2020, after final approval by the Compensation Committee. The Company issued 126,198 time-based restricted stock units during the three months ended October 31, 2020. The Company issued 701,392 time-based restricted stock units during the nine months ended October 31, 2020. These time-based restricted stock units are subject to the same four-year vesting period as the previously granted units. Restricted stock unit activity for the nine months ended October 31, 2020 are as follows: Restricted stock units Outstanding, February 1, 2020 1,447,418 Granted in nine months ended October 31, 2020 701,392 Vested (76,915) Forfeited and expired (93,915) Outstanding, October 31, 2020 1,977,980 For the three months ended October 31, 2020 and 2019, the Company recognized $2,684 and $957 in restricted stock unit compensation expense, respectively. For the nine months ended October 31, 2020 and 2019, the Company recognized $7,505 and $1,781 in restricted stock unit compensation expense, respectively, with $33,424 remaining of total unrecognized compensation costs related to these awards as of October 31, 2020. The total unrecognized costs are expected to be recognized over a weighted-average term of 3.2 years. For the three and nine months ended October 31, 2020, stock-based compensation expense for restricted stock units includes $8 and $25 related to restricted stock units issued in connection with the Vital Score acquisition in December 2018. For the three and nine months ended October 31, 2019, stock-based compensation expense includes $10 and $30 related to restricted stock units issued in connection with the Vital Score acquisition. As of October 31, 2020, there is $66 of total unrecognized compensation cost related to these awards.

Stock warrants

Stock warrants	9 Months Ended
	Oct. 31, 2020
Warrants and Rights Note Disclosure [Abstract]
Stock warrants	Stock warrants As of October 31, 2020 and January 31, 2020, there were 75,137 common stock warrants outstanding. These remaining common stock warrants were issued with an exercise price of $8.02 per share. If unexercised, each of these warrants will expire on February 28, 2029. On November 6, 2020, the remaining 75,137 common stock warrants were exercised through a net share settlement. The Company issued 60,388 shares in the net share exercise transaction.

Fair value measurements

Fair value measurements	9 Months Ended
	Oct. 31, 2020
Fair Value Disclosures [Abstract]
Fair value measurements	Fair value measurements Certain assets and liabilities are carried at fair value under generally accepted accounting principles. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable: Level 1—Quoted prices in active markets for identical assets or liabilities. Level 2—Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities or other inputs that are observable or can be corroborated by observable market. Level 3—Unobservable inputs which are supported by little or no market activity and that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques. The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The following table presents information about the Company's assets and liabilities that are measured at fair value as of October 31, 2020 and indicates the classification of each item within the fair value hierarchy (in thousands): Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Balance as of October 31, 2020 Money market mutual funds $ 237,499 $ — $ — $ 237,499 Foreign currency derivative contracts $ — $ 34 $ — $ 34 Total assets $ 237,499 $ 34 $ — $ 237,533 The following table presents information about the Company's assets and liabilities that are measured at fair value as of January 31, 2020 and indicates the classification of each item within the fair value hierarchy (in thousands): Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Balance as of January 31, 2020 Money market mutual funds $ 86,600 $ — $ — $ 86,600 Foreign currency derivative contracts — 58 — 58 Total assets $ 86,600 $ 58 $ — $ 86,658 The carrying value of the Company’s short-term financial instruments, including accounts receivable and accounts payable approximate fair value due to the short-term nature of these instruments. The Company uses certain derivative financial instruments as part of its risk management strategy to reduce its foreign currency risk. The Company does not designate any derivatives as hedges in accordance with ASC 815 Derivatives and Hedging . The Company recognizes all derivatives on the balance sheet at fair value based on quotes obtained from financial institutions. The fair value of its foreign currency contracts as of October 31, 2020 was an asset of $34, which is included in prepaid expenses and other current assets on the accompanying balance sheet. The fair value of its foreign currency contracts as of January 31, 2020 was an asset of $58, which is included in prepaid and other current assets on the accompanying balance sheet. The fair value of the foreign currency contracts are considered Level 2 in the fair value hierarchy as of October 31, 2020 and January 31, 2020, respectively. The Company includes gains and losses on its foreign currency forward contracts within other income (expense). During the three and nine months ended October 31, 2020, the Company recognized a gain of $59 and a loss of $250, respectively. During the three and nine months ended October 31, 2019, the Company recognized gains of $327 and $256, respectively. As the Company refinanced all of its debt on February 28, 2019 and again on May 5, 2020 (See Note 6), the Company's debt bears interest at floating rates, and there have been no significant changes in the Company's credit risk since the issuance of the debt, the Company believes that the face value of its outstanding debt at October 31, 2020 and January 31, 2020 approximates fair value. The Company did not have any transfers of assets and liabilities between levels of the fair value measurement hierarchy during the three and nine months ended October 31, 2020 and 2019.

Leases

Leases	9 Months Ended
	Oct. 31, 2020
Leases [Abstract]
Leases	Leases (a) Phreesia as Lessee The Company leases office premises in New York, North Carolina, and Ottawa, and data center space in Virginia under operating leases which expire on various dates through March 2024. Certain of these arrangements have escalating rent payment provisions or optional renewal clauses. The table below only considers lease obligations through the renewal date as the Company is not reasonably certain to elect the option to extend its leases beyond the option date. No arrangements contain residual value guarantees or restrictions imposed on the leases. We are also committed to pay a portion of the actual operating expenses under certain of these lease agreements. These operating expenses are not included in the table below. The operating right-of-use assets were calculated as the present value of operating lease liabilities, less the amount of unamortized tenant improvement allowance and deferred rent. The discount rate used was the Company’s incremental borrowing rate given that the implicit rate to each lease was not readily determinable. The Company also entered into various finance lease arrangements of computer equipment. These agreements are typically for two Supplemental balance sheet information related to operating and finance leases as of October 31, 2020 was as follows: October 31, 2020 Operating leases: Lease right-of-use assets $ 3,192 Lease liabilities, current $ 1,288 Lease liabilities, noncurrent 2,158 Total operating lease liabilities $ 3,446 Finance leases: Property and equipment, at cost $ 17,078 Accumulated depreciation (9,555) Property and equipment, net $ 7,523 Lease liabilities (included in Current portion of debt and finance leases) $ 3,018 Lease liabilities, noncurrent (included in Long-term debt and finance leases) 4,589 Total finance lease liabilities $ 7,607 For office leases and leased equipment, the Company has elected the practical expedient to not separate lease and non-lease components, and as such, the variable lease cost primarily represents variable payments such as common area maintenance, utilities and equipment maintenance. As of October 31, 2020, for operating leases, the weighted-average remaining lease term is 2.7 years and the weighted-average discount rate is 3.5%. As of October 31, 2020, for finance leases, the weighted-average remaining lease term is 2.8 years, and the weighted-average discount rate is 4.9%. The components of lease expense for the nine months ended October 31, 2020 were as follows: October 31, 2020 Operating leases: Operating lease cost $ 1,300 Variable lease cost 191 Total operating lease cost $ 1,491 Finance leases: Amortization of right-of-use assets $ 2,278 Interest on lease liabilities 236 Total finance lease cost $ 2,514 The following represents a schedule of maturing lease commitments for operating and finance leases as of October 31, 2020: October 31, 2020 Operating Finance Maturity of lease liabilities Fiscal 2021 (remaining three months) $ 434 $ 850 Fiscal year ending January 31, 2022 1,228 3,139 2023 1,142 2,352 2024 758 1,290 2025 $ 52 $ 472 Total future minimum lease payments $ 3,614 $ 8,103 Less: interest (168) (496) Present value of lease liabilities $ 3,446 $ 7,607 Future minimum lease payments under non-cancelable operating leases as of January 31, 2020 under ASC 840 were as follows: January 31, 2020 Operating Fiscal year ending January 31, 2021 $ 1,824 2022 819 2023 464 2024 277 $ 3,384 Other supplemental cash flow information for the nine months ended October 31, 2020 was as follows: October 31, 2020 Supplemental cash flow information Cash paid for amounts included in the measurement of lease liabilities: Operating cash used for operating leases $ 1,234 Operating cash used for finance leases 236 Financing cash used for finance leases 1,797 Total $ 3,267 Right-of-use assets obtained in exchange for lease liabilities: Operating $ 4,420 Finance 6,050 Total $ 10,470 An initial right-of-use asset of $2,741 for operating leases was recognized as a non-cash asset addition in connection with the adoption of ASC 842. Cash paid for amounts included in the present value of operating lease liabilities was $1,234 during the nine months ended October 31, 2020 and is included in cash (used in) provided by operating activities. (b) Phreesia as Lessor In connection with the patient intake and registration process, Phreesia offers its customers the ability to lease PhreesiaPads and Arrival Stations along with their monthly subscription. These rentals fall under the guidance of ASC 842. The Company elected the practical expedient to not separate lease and non-lease components. More specifically, all contractual hardware maintenance is included with the hardware lease components. The leases contain no variable lease payments, no options to extend the lease that are reasonably certain to be exercised, and do not give the lessee an option to purchase the hardware at the end of the lease term. Additionally, the lease term does not represent a major part of the remaining economic life of the assets, and the present value of the lease payments does not equal or exceed substantially all of the fair value of the assets. As a result, all leased hardware in the SaaS arrangements are classified as operating leases. During the three and nine months ended October 31, 2020, the Company recognized $1,593 and $4,732, respectively, in subscription and related services revenue related to the leasing of PhreesiaPads and Arrival Stations.
Leases	Leases (a) Phreesia as Lessee The Company leases office premises in New York, North Carolina, and Ottawa, and data center space in Virginia under operating leases which expire on various dates through March 2024. Certain of these arrangements have escalating rent payment provisions or optional renewal clauses. The table below only considers lease obligations through the renewal date as the Company is not reasonably certain to elect the option to extend its leases beyond the option date. No arrangements contain residual value guarantees or restrictions imposed on the leases. We are also committed to pay a portion of the actual operating expenses under certain of these lease agreements. These operating expenses are not included in the table below. The operating right-of-use assets were calculated as the present value of operating lease liabilities, less the amount of unamortized tenant improvement allowance and deferred rent. The discount rate used was the Company’s incremental borrowing rate given that the implicit rate to each lease was not readily determinable. The Company also entered into various finance lease arrangements of computer equipment. These agreements are typically for two Supplemental balance sheet information related to operating and finance leases as of October 31, 2020 was as follows: October 31, 2020 Operating leases: Lease right-of-use assets $ 3,192 Lease liabilities, current $ 1,288 Lease liabilities, noncurrent 2,158 Total operating lease liabilities $ 3,446 Finance leases: Property and equipment, at cost $ 17,078 Accumulated depreciation (9,555) Property and equipment, net $ 7,523 Lease liabilities (included in Current portion of debt and finance leases) $ 3,018 Lease liabilities, noncurrent (included in Long-term debt and finance leases) 4,589 Total finance lease liabilities $ 7,607 For office leases and leased equipment, the Company has elected the practical expedient to not separate lease and non-lease components, and as such, the variable lease cost primarily represents variable payments such as common area maintenance, utilities and equipment maintenance. As of October 31, 2020, for operating leases, the weighted-average remaining lease term is 2.7 years and the weighted-average discount rate is 3.5%. As of October 31, 2020, for finance leases, the weighted-average remaining lease term is 2.8 years, and the weighted-average discount rate is 4.9%. The components of lease expense for the nine months ended October 31, 2020 were as follows: October 31, 2020 Operating leases: Operating lease cost $ 1,300 Variable lease cost 191 Total operating lease cost $ 1,491 Finance leases: Amortization of right-of-use assets $ 2,278 Interest on lease liabilities 236 Total finance lease cost $ 2,514 The following represents a schedule of maturing lease commitments for operating and finance leases as of October 31, 2020: October 31, 2020 Operating Finance Maturity of lease liabilities Fiscal 2021 (remaining three months) $ 434 $ 850 Fiscal year ending January 31, 2022 1,228 3,139 2023 1,142 2,352 2024 758 1,290 2025 $ 52 $ 472 Total future minimum lease payments $ 3,614 $ 8,103 Less: interest (168) (496) Present value of lease liabilities $ 3,446 $ 7,607 Future minimum lease payments under non-cancelable operating leases as of January 31, 2020 under ASC 840 were as follows: January 31, 2020 Operating Fiscal year ending January 31, 2021 $ 1,824 2022 819 2023 464 2024 277 $ 3,384 Other supplemental cash flow information for the nine months ended October 31, 2020 was as follows: October 31, 2020 Supplemental cash flow information Cash paid for amounts included in the measurement of lease liabilities: Operating cash used for operating leases $ 1,234 Operating cash used for finance leases 236 Financing cash used for finance leases 1,797 Total $ 3,267 Right-of-use assets obtained in exchange for lease liabilities: Operating $ 4,420 Finance 6,050 Total $ 10,470 An initial right-of-use asset of $2,741 for operating leases was recognized as a non-cash asset addition in connection with the adoption of ASC 842. Cash paid for amounts included in the present value of operating lease liabilities was $1,234 during the nine months ended October 31, 2020 and is included in cash (used in) provided by operating activities. (b) Phreesia as Lessor In connection with the patient intake and registration process, Phreesia offers its customers the ability to lease PhreesiaPads and Arrival Stations along with their monthly subscription. These rentals fall under the guidance of ASC 842. The Company elected the practical expedient to not separate lease and non-lease components. More specifically, all contractual hardware maintenance is included with the hardware lease components. The leases contain no variable lease payments, no options to extend the lease that are reasonably certain to be exercised, and do not give the lessee an option to purchase the hardware at the end of the lease term. Additionally, the lease term does not represent a major part of the remaining economic life of the assets, and the present value of the lease payments does not equal or exceed substantially all of the fair value of the assets. As a result, all leased hardware in the SaaS arrangements are classified as operating leases. During the three and nine months ended October 31, 2020, the Company recognized $1,593 and $4,732, respectively, in subscription and related services revenue related to the leasing of PhreesiaPads and Arrival Stations.
Leases	Leases (a) Phreesia as Lessee The Company leases office premises in New York, North Carolina, and Ottawa, and data center space in Virginia under operating leases which expire on various dates through March 2024. Certain of these arrangements have escalating rent payment provisions or optional renewal clauses. The table below only considers lease obligations through the renewal date as the Company is not reasonably certain to elect the option to extend its leases beyond the option date. No arrangements contain residual value guarantees or restrictions imposed on the leases. We are also committed to pay a portion of the actual operating expenses under certain of these lease agreements. These operating expenses are not included in the table below. The operating right-of-use assets were calculated as the present value of operating lease liabilities, less the amount of unamortized tenant improvement allowance and deferred rent. The discount rate used was the Company’s incremental borrowing rate given that the implicit rate to each lease was not readily determinable. The Company also entered into various finance lease arrangements of computer equipment. These agreements are typically for two Supplemental balance sheet information related to operating and finance leases as of October 31, 2020 was as follows: October 31, 2020 Operating leases: Lease right-of-use assets $ 3,192 Lease liabilities, current $ 1,288 Lease liabilities, noncurrent 2,158 Total operating lease liabilities $ 3,446 Finance leases: Property and equipment, at cost $ 17,078 Accumulated depreciation (9,555) Property and equipment, net $ 7,523 Lease liabilities (included in Current portion of debt and finance leases) $ 3,018 Lease liabilities, noncurrent (included in Long-term debt and finance leases) 4,589 Total finance lease liabilities $ 7,607 For office leases and leased equipment, the Company has elected the practical expedient to not separate lease and non-lease components, and as such, the variable lease cost primarily represents variable payments such as common area maintenance, utilities and equipment maintenance. As of October 31, 2020, for operating leases, the weighted-average remaining lease term is 2.7 years and the weighted-average discount rate is 3.5%. As of October 31, 2020, for finance leases, the weighted-average remaining lease term is 2.8 years, and the weighted-average discount rate is 4.9%. The components of lease expense for the nine months ended October 31, 2020 were as follows: October 31, 2020 Operating leases: Operating lease cost $ 1,300 Variable lease cost 191 Total operating lease cost $ 1,491 Finance leases: Amortization of right-of-use assets $ 2,278 Interest on lease liabilities 236 Total finance lease cost $ 2,514 The following represents a schedule of maturing lease commitments for operating and finance leases as of October 31, 2020: October 31, 2020 Operating Finance Maturity of lease liabilities Fiscal 2021 (remaining three months) $ 434 $ 850 Fiscal year ending January 31, 2022 1,228 3,139 2023 1,142 2,352 2024 758 1,290 2025 $ 52 $ 472 Total future minimum lease payments $ 3,614 $ 8,103 Less: interest (168) (496) Present value of lease liabilities $ 3,446 $ 7,607 Future minimum lease payments under non-cancelable operating leases as of January 31, 2020 under ASC 840 were as follows: January 31, 2020 Operating Fiscal year ending January 31, 2021 $ 1,824 2022 819 2023 464 2024 277 $ 3,384 Other supplemental cash flow information for the nine months ended October 31, 2020 was as follows: October 31, 2020 Supplemental cash flow information Cash paid for amounts included in the measurement of lease liabilities: Operating cash used for operating leases $ 1,234 Operating cash used for finance leases 236 Financing cash used for finance leases 1,797 Total $ 3,267 Right-of-use assets obtained in exchange for lease liabilities: Operating $ 4,420 Finance 6,050 Total $ 10,470 An initial right-of-use asset of $2,741 for operating leases was recognized as a non-cash asset addition in connection with the adoption of ASC 842. Cash paid for amounts included in the present value of operating lease liabilities was $1,234 during the nine months ended October 31, 2020 and is included in cash (used in) provided by operating activities. (b) Phreesia as Lessor In connection with the patient intake and registration process, Phreesia offers its customers the ability to lease PhreesiaPads and Arrival Stations along with their monthly subscription. These rentals fall under the guidance of ASC 842. The Company elected the practical expedient to not separate lease and non-lease components. More specifically, all contractual hardware maintenance is included with the hardware lease components. The leases contain no variable lease payments, no options to extend the lease that are reasonably certain to be exercised, and do not give the lessee an option to purchase the hardware at the end of the lease term. Additionally, the lease term does not represent a major part of the remaining economic life of the assets, and the present value of the lease payments does not equal or exceed substantially all of the fair value of the assets. As a result, all leased hardware in the SaaS arrangements are classified as operating leases. During the three and nine months ended October 31, 2020, the Company recognized $1,593 and $4,732, respectively, in subscription and related services revenue related to the leasing of PhreesiaPads and Arrival Stations.

Commitments and contingencies

Commitments and contingencies	9 Months Ended
	Oct. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and contingencies	Commitments and contingenciesIn the ordinary course of business, the Company may be subject from time to time to various proceedings, lawsuits, disputes or claims. Although the Company cannot predict with assurance the outcome of any litigation, the Company does not believe there are currently any such actions that, if resolved unfavorably, would have a material impact on its financial condition, results of operations or cash flows.

Income taxes

Income taxes	9 Months Ended
	Oct. 31, 2020
Income Tax Disclosure [Abstract]
Income taxes	Income taxes For the three and nine months ended October 31, 2020, the Company recorded a tax provision of $194 and $371, respectively, compared to a tax provision of $64 and $183, respectively, for the corresponding three and nine month periods in the prior year. Our provision for income taxes was 2.0% and 1.1% of loss before income taxes for the nine months ended October 31, 2020 and 2019, respectively. The Company's effective tax rate differs from the U.S. statutory tax rate of 21% primarily because the Company records a valuation allowance against the majority of its deferred tax assets, and due to foreign income tax expense recorded for the Company's Canada branch. Deferred tax assets and deferred tax liabilities are recognized based on temporary differences between the financial reporting and tax basis of assets and liabilities using statutory rates. Management of the Company has evaluated the positive and negative evidence pertaining to the realizability of its deferred tax assets, including the Company’s history of losses, and concluded that it is more likely than not that the Company will not recognize the benefits for the majority of its deferred tax assets. On the basis of this evaluation, the Company has recorded a valuation allowance against its deferred tax assets that are not more likely than not to be realized at October 31, 2020 and January 31, 2020.

Net loss per share attributable

Net loss per share attributable to common stockholders	9 Months Ended
	Oct. 31, 2020
Earnings Per Share [Abstract]
Net loss per share attributable to common stockholders	Net loss per share attributable to common stockholders Basic and diluted net loss per share attributable to common stockholders was calculated as follows: Three months ended October 31, Nine months ended October 31, 2020 2019 2020 2019 Numerator: Net loss $ (6,713) $ (2,437) $ (19,196) $ (16,625) Preferred stock dividend paid — — — (14,955) Accretion of redeemable convertible preferred stock to redemption value — — — (56,175) Net loss attributable to common stockholders $ (6,713) $ (2,437) $ (19,196) $ (87,755) Denominator: Weighted-average shares of common stock outstanding, basic and diluted 38,511,370 35,790,951 37,855,503 15,007,247 Net loss per share attributable to common stockholders $ (0.17) $ (0.07) $ (0.51) $ (5.85) The Company’s potential dilutive securities, which include convertible preferred, stock options, restricted stock units and outstanding warrants to purchase shares of common and preferred stock, have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. Therefore, the weighted-average number of common shares outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same. The following potential common shares, presented based on amounts outstanding at each period end, were excluded from the calculation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect: As of October 31, 2020 2019 Stock options to purchase common stock and restricted stock units 5,830,142 6,645,106 Warrants to purchase common stock 75,137 228,178 5,905,279 6,873,284

Related party transactions

Related party transactions	9 Months Ended
	Oct. 31, 2020
Related Party Transactions [Abstract]
Related party transactions	Related party transactionsThe Company recognized revenue totaling approximately $1,223 from an affiliate of a stockholder of the Company for the three months ended October 31, 2019. The Company recognized revenue totaling approximately $2,425 and $4,098 from an affiliate of a stockholder of the Company for the nine months ended October 31, 2020 and 2019, respectively. Accounts receivable from the affiliate totaled approximately $2,072 as of January 31, 2020, The entity was no longer a related party as of October 31, 2020.

Summary of significant accoun_2

Summary of significant accounting policies (Policies)	9 Months Ended
	Oct. 31, 2020
Accounting Policies [Abstract]
Basis of presentation	Basis of presentationThe accompanying financial statements have been prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) and include the accounts of Phreesia, Inc. and its branch operation in Canada.
Fiscal year	Fiscal yearThe Company’s fiscal year ends on January 31. References to fiscal 2021 and 2020 refer to the fiscal years ended January 31, 2021 and January 31, 2020, respectively.
Reclassifications	ReclassificationsCertain reclassifications have been made to the prior period presentation to conform to the current period presentation. In the Company's balance sheet as of January 31, 2020, the Company has reclassified $2.3 million from current portion of finance lease liabilities to current portion of debt and finance lease liabilities, and the Company has reclassified $2.1 million from long-term finance leases to long-term debt and finance leases.
Use of estimates	Use of estimatesThe preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates and assumptions on historical experience, known trends and events and various other factors that management believes to be reasonable under the circumstances, the results of which form the basis for making judgments. Although management believes its estimates and assumptions are reasonable under the circumstances at the time they are made, they are based upon information available at the time they are made. Management evaluates the estimates and assumptions on an ongoing basis and, if necessary, makes adjustments. Actual results may differ from those estimates made under different assumptions or circumstances. The most significant assumptions and estimates relate to the accounts receivable allowance, capitalized internal-use software, the determination of the useful lives of property and equipment and capitalized software, the fair value of securities underlying stock-based compensation awards issued prior to our initial public offering, the fair value of business acquisitions, and the realization of deferred tax assets.
Concentrations of credit risk	Concentrations of credit riskFinancial instruments which potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable and settlement assets. The Company’s cash and cash equivalents are held by established financial institutions. The Company does not require collateral from its customers and generally requires payment within 30 to 60 days of billing. Settlement assets are amounts due from well-established payment processing companies and normally take one or two business days to settle which mitigates the associated risk of concentration. The Company has one third-party payment processor.The Company’s customers are primarily physician’s offices located in the United States and pharmaceutical companies.
New accounting pronouncements	New accounting pronouncements Impact of recently adopted accounting pronouncements On May 1, 2020, the Company adopted ASU 2018-15, Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract, which is intended to align the requirements for capitalization of implementation costs incurred in a cloud computing arrangement that is a service contract with the existing guidance for internal-use software. The guidance requires capitalized costs to be included within prepaid expenses and the guidance requires amortization of capitalized costs to be included in the same line as the associated cloud subscription costs in the statement of operations. The Company adopted ASU 2018-15 prospectively for implementation costs incurred subsequent to May 1, 2020. See Note 4 - Composition of Certain Financial Statement Captions for additional information. On February 1, 2020, the Company adopted the Financial Accounting Standards Board's (FASB) Accounting Standard Update (ASU) No. 2016-02, Leases (Topic 842) (ASC 842) which requires lessees to record most leases on their balance sheets but to recognize the expenses in their statement of operations in a manner similar to the prior standard. Topic 842 states that a lessee would recognize a lease liability for the obligation to make lease payments and a right-of-use asset for the right to use the underlying asset for the lease term. The Company adopted the new lease guidance using a modified retrospective transition method applied to those leases which were not completed as of February 1, 2020. As a result, the Company was not required to adjust its comparative period financial information for effects of the standard or make the new required lease disclosures for the periods before the date of adoption. The Company elected the ‘package of practical expedients,’ which permits the Company not to reassess under the new standard our prior conclusions about lease identification, lease classification and initial direct costs. The Company did not elect the use-of-hindsight practical expedient. The new standard also provides practical expedients for an entity’s ongoing accounting. The Company elected the short-term lease recognition exemption for all of its leases. This means, for those leases that qualify, the Company will not recognize right-of-use assets or lease liabilities, including existing short-term leases as of the transition date. The Company also elected the practical expedient to not separate lease and non-lease components for its office and computer equipment leases. Upon adoption of Topic 842 the Company recognized operating lease right-of-use assets and operating lease liabilities related to our office leases of $2,741 and $2,928, respectively. The Company’s accounting for lessee finance and all lessor leases remains substantially unchanged from legacy guidance. The standard did not have a significant impact on our statements of operations or statements of cash flows. No adjustment to accumulated deficit was recorded because the adoption did not change the Company's net assets. In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820) : Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement (ASU 2018-13). ASU 2018-13 updates the disclosure requirements for fair value measurements and is effective for financial statements issued for fiscal years beginning after December 15, 2019. The Company adopted the new guidance effective February 1, 2020, and it did not have a material effect on its financial statements. On February 1, 2020, the Company adopted ASU 2016-13, Financial Instruments - Credit Losses . The update requires the recognition of all losses expected over the life of a financial instrument upon origination or purchase of the instrument. The Company adopted this update using a modified retrospective method. No adjustment to accumulated deficit was recorded as a result of the adoption of this standard, which did not have a material impact on the Company's financial statements. Recent accounting pronouncements not yet adopted There are no recently issued accounting pronouncements the Company has not yet adopted that will materially impact the Company's financial statements.

Composition of certain financ_2

Composition of certain financial statement captions (Tables)	9 Months Ended
	Oct. 31, 2020
Composition Of Certain Financial Statement [Abstract]
Schedule of accrued liabilities	Accrued expenses as of October 31, 2020 and January 31, 2020 are as follows: October 31, 2020 January 31, 2020 Payroll-related expenses and taxes $ 7,846 $ 5,032 Payment processing fees liability 2,634 2,738 Other 2,182 1,473 Total $ 12,662 $ 9,243
Schedule of property and equipment	Property and equipment as of October 31, 2020 and January 31, 2020 are as follows: Useful Life (years) October 31, 2020 January 31, 2020 PhreesiaPads and Arrivals Stations 3 $ 29,857 $ 26,389 Computer equipment 3 25,990 18,394 Computer software 3 3,010 2,297 Hardware development 3 1,024 1,024 Furniture and fixtures 7 743 743 Leasehold improvements 2 1,201 1,191 Total property and equipment $ 61,825 $ 50,038 Less accumulated depreciation and amortization (42,665) (35,551) Property and equipment — net $ 19,160 $ 14,487
Schedule of intangible assets	The following presents the details of intangible assets as of October 31, 2020 and January 31, 2020: Useful Life (years) October 31, 2020 January 31, 2020 Acquired technology 5 $ 490 $ 490 Customer relationship 7 980 980 Total intangible assets, gross carrying value $ 1,470 $ 1,470 Less accumulated amortization (450) (271) Net carrying value $ 1,020 $ 1,199
Schedule of estimated amortization expense for intangible assets	The estimated amortization expense for intangible assets for the next five years and thereafter is as follows as of October 31, 2020: October 31, 2020 2021 (Remaining three months) $ 60 Fiscal Years Ending January 31, 2022 238 2023 238 2024 224 2025 - thereafter 260 Total $ 1,020
Schedule of accounts receivable	Accounts receivable as of October 31, 2020 and January 31, 2020 are as follows: October 31, 2020 January 31, 2020 Billed $ 26,000 $ 22,245 Unbilled 2,344 676 Total accounts receivable, gross $ 28,344 $ 22,921 Less accounts receivable allowances (750) (943) Total accounts receivable $ 27,594 $ 21,978
Schedule of allowance for credit losses	Activity in our allowance for doubtful accounts was as follows for the nine months ended October 31, 2020: October 31, 2020 Balance, January 31, 2020 $ 943 Bad debt expense 396 Write-offs and adjustments (589) Balance, October 31, 2020 $ 750
Schedule of prepaid and other current assets	Prepaid and other current assets as of October 31, 2020 and January 31, 2020 are as follows: October 31, 2020 January 31, 2020 Prepaid software and business systems 1,994 $ 1,611 Prepaid PhreesiaPads 394 645 Prepaid data center expenses 350 751 Prepaid insurance 1,969 1,259 Other prepaid expenses and other current assets 2,118 891 Total prepaid and other current assets $ 6,825 $ 5,157

Revenue (Tables)

Revenue (Tables)	9 Months Ended
	Oct. 31, 2020
Revenue from Contract with Customer [Abstract]
Rollforward of contract assets and contract liabilities	The following table represents a roll-forward of contract assets: Contract assets (unbilled accounts receivable) January 31, 2020 $ 676 Amount transferred to receivables from beginning balance of contract assets (676) Contract asset additions, net of reclassification to receivables 2,344 October 31, 2020 $ 2,344 The following table represents a roll-forward of contract liabilities: Contract liabilities (deferred revenue) January 31, 2020 $ 5,401 Revenue recognized that was included in deferred revenue at the beginning of the period (5,004) Revenue recognized that was not included in deferred revenue at the beginning of the period (1,168) Increases due to invoicing prior to satisfaction of performance obligations 7,394 October 31, 2020 $ 6,623
Deferred contract acquisition costs	The following table represents a roll forward of deferred contract acquisition costs: Beginning balance, January 31, 2020 $ 3,314 Additions to deferred contract acquisition costs 1,901 Amortization of deferred contract acquisition costs (2,280) Ending balance, October 31, 2020 2,935 Deferred contract acquisition costs, current (to be amortized in next 12 months) 1,708 Deferred contract acquisition costs, non-current 1,227 Total deferred contract acquisition costs $ 2,935

Debt and Finance Lease Liabil_2

Debt and Finance Lease Liabilities (Tables)	9 Months Ended
	Oct. 31, 2020
Debt Disclosure [Abstract]
Schedule of long-term debt instruments	As of October 31, 2020 and January 31, 2020, the Company had the following outstanding debt and finance lease liabilities: October 31, 2020 January 31, 2020 Revolving credit facility $ 20,663 $ — Term loan — 20,000 Finance leases 7,607 3,612 Other debt 2,146 808 Accrued interest and payments 65 381 Total debt and finance lease liabilities, before original issue discount 30,481 24,801 Less deferred financing costs and original issue discount (1,320) (937) Debt and finance lease liabilities 29,161 23,864 Less - current portion of debt and finance lease liabilities (4,722) (2,324) Long term debt and finance lease liabilities $ 24,439 $ 21,540
Schedule of maturities of long-term debt	Maturities of debt, including finance leases, in each of the next five years and thereafter are as follows: Total Debt Finance Leases Fiscal 2021 (remaining three months) $ 1,509 $ 845 $ 664 Fiscal year ending January 31: 2022 4,050 1,077 2,973 2023 2,442 184 2,258 2024 1,290 40 1,250 2025 21,190 20,728 462 Total long-term debt and finance lease maturities $ 30,481 $ 22,874 $ 7,607

Equity-based compensation (Tabl

Equity-based compensation (Tables)	9 Months Ended
	Oct. 31, 2020
Share-based Payment Arrangement [Abstract]
Schedule of stock option activity	Stock option activity for the nine months ended October 31, 2020 is as follows: Number of Weighted- Weighted- Aggregate Intrinsic Outstanding — January 31, 2020 5,516,452 $ 3.80 Granted in nine months ended October 31, 2020 — $ — Exercised (1,610,207) $ 2.08 Forfeited and expired (54,083) $ 7.31 Outstanding and expected to vest — October 31, 2020 3,852,162 $ 4.46 6.03 $ 125,217 Exercisable — October 31, 2020 2,625,365 $ 3.12 5.09 $ 88,856 Amount vested in nine months ended October 31, 2020 476,680 $ 5.52
Schedule of restricted stock unit activity	Restricted stock unit activity for the nine months ended October 31, 2020 are as follows: Restricted stock units Outstanding, February 1, 2020 1,447,418 Granted in nine months ended October 31, 2020 701,392 Vested (76,915) Forfeited and expired (93,915) Outstanding, October 31, 2020 1,977,980

Fair value measurements (Tables

Fair value measurements (Tables)	9 Months Ended
	Oct. 31, 2020
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	The following table presents information about the Company's assets and liabilities that are measured at fair value as of October 31, 2020 and indicates the classification of each item within the fair value hierarchy (in thousands): Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Balance as of October 31, 2020 Money market mutual funds $ 237,499 $ — $ — $ 237,499 Foreign currency derivative contracts $ — $ 34 $ — $ 34 Total assets $ 237,499 $ 34 $ — $ 237,533 The following table presents information about the Company's assets and liabilities that are measured at fair value as of January 31, 2020 and indicates the classification of each item within the fair value hierarchy (in thousands): Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Balance as of January 31, 2020 Money market mutual funds $ 86,600 $ — $ — $ 86,600 Foreign currency derivative contracts — 58 — 58 Total assets $ 86,600 $ 58 $ — $ 86,658

Leases (Tables)

Leases (Tables)	9 Months Ended
	Oct. 31, 2020
Leases [Abstract]
Schedule of supplemental balance sheet information	Supplemental balance sheet information related to operating and finance leases as of October 31, 2020 was as follows: October 31, 2020 Operating leases: Lease right-of-use assets $ 3,192 Lease liabilities, current $ 1,288 Lease liabilities, noncurrent 2,158 Total operating lease liabilities $ 3,446 Finance leases: Property and equipment, at cost $ 17,078 Accumulated depreciation (9,555) Property and equipment, net $ 7,523 Lease liabilities (included in Current portion of debt and finance leases) $ 3,018 Lease liabilities, noncurrent (included in Long-term debt and finance leases) 4,589 Total finance lease liabilities $ 7,607
Schedule of lease expense and cash flow information	The components of lease expense for the nine months ended October 31, 2020 were as follows: October 31, 2020 Operating leases: Operating lease cost $ 1,300 Variable lease cost 191 Total operating lease cost $ 1,491 Finance leases: Amortization of right-of-use assets $ 2,278 Interest on lease liabilities 236 Total finance lease cost $ 2,514 Other supplemental cash flow information for the nine months ended October 31, 2020 was as follows: October 31, 2020 Supplemental cash flow information Cash paid for amounts included in the measurement of lease liabilities: Operating cash used for operating leases $ 1,234 Operating cash used for finance leases 236 Financing cash used for finance leases 1,797 Total $ 3,267 Right-of-use assets obtained in exchange for lease liabilities: Operating $ 4,420 Finance 6,050 Total $ 10,470
Maturities of operating leases	The following represents a schedule of maturing lease commitments for operating and finance leases as of October 31, 2020: October 31, 2020 Operating Finance Maturity of lease liabilities Fiscal 2021 (remaining three months) $ 434 $ 850 Fiscal year ending January 31, 2022 1,228 3,139 2023 1,142 2,352 2024 758 1,290 2025 $ 52 $ 472 Total future minimum lease payments $ 3,614 $ 8,103 Less: interest (168) (496) Present value of lease liabilities $ 3,446 $ 7,607
Maturities of finance leases	The following represents a schedule of maturing lease commitments for operating and finance leases as of October 31, 2020: October 31, 2020 Operating Finance Maturity of lease liabilities Fiscal 2021 (remaining three months) $ 434 $ 850 Fiscal year ending January 31, 2022 1,228 3,139 2023 1,142 2,352 2024 758 1,290 2025 $ 52 $ 472 Total future minimum lease payments $ 3,614 $ 8,103 Less: interest (168) (496) Present value of lease liabilities $ 3,446 $ 7,607
Schedule of aggregate minimum net rental payments	Future minimum lease payments under non-cancelable operating leases as of January 31, 2020 under ASC 840 were as follows: January 31, 2020 Operating Fiscal year ending January 31, 2021 $ 1,824 2022 819 2023 464 2024 277 $ 3,384

Net loss per share attributab_2

Net loss per share attributable to common stockholders (Tables)	9 Months Ended
	Oct. 31, 2020
Earnings Per Share [Abstract]
Schedule of earnings per share, basic and diluted	Basic and diluted net loss per share attributable to common stockholders was calculated as follows: Three months ended October 31, Nine months ended October 31, 2020 2019 2020 2019 Numerator: Net loss $ (6,713) $ (2,437) $ (19,196) $ (16,625) Preferred stock dividend paid — — — (14,955) Accretion of redeemable convertible preferred stock to redemption value — — — (56,175) Net loss attributable to common stockholders $ (6,713) $ (2,437) $ (19,196) $ (87,755) Denominator: Weighted-average shares of common stock outstanding, basic and diluted 38,511,370 35,790,951 37,855,503 15,007,247 Net loss per share attributable to common stockholders $ (0.17) $ (0.07) $ (0.51) $ (5.85)
Schedule of shares excluded from computation of diluted net loss per share	The following potential common shares, presented based on amounts outstanding at each period end, were excluded from the calculation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect: As of October 31, 2020 2019 Stock options to purchase common stock and restricted stock units 5,830,142 6,645,106 Warrants to purchase common stock 75,137 228,178 5,905,279 6,873,284

Background and liquidity (Detai

Background and liquidity (Detail) - USD ($) $ / shares in Units, $ in Thousands	Oct. 23, 2020	Dec. 17, 2019	Jul. 22, 2019	Oct. 31, 2020	Jul. 31, 2019	Jan. 31, 2020	Oct. 31, 2020	Oct. 31, 2019
Background And Liquidity [Line Items]
Issuance of common stock in public offering, net of issuance costs (in shares)	5,750,000
Issue price per share (in dollars per share)	$ 32
Proceeds from initial public offering							$ 174,800	$ 130,781
Deferred offering costs							$ 226	$ 5,944
Conversion of preferred stock into common stock and cancellation of redeemable preferred stock (in shares)						757,625
Proceeds from secondary offering	$ 174,510
Number of months the company have sufficient to fund its operations							12 months
Common Stock
Background And Liquidity [Line Items]
Issuance of common stock in public offering, net of issuance costs (in shares)		7,762,500		5,750,000	7,812,500
Deferred offering costs		$ 1,047
Conversion of preferred stock into common stock and cancellation of redeemable preferred stock (in shares)			25,311,525		25,311,535
IPO
Background And Liquidity [Line Items]
Issuance of common stock in public offering, net of issuance costs (in shares)			7,812,500
Issue price per share (in dollars per share)			$ 18
Proceeds from initial public offering			$ 130,781
Underwriting discounts and commission			9,844
IPO | Common Stock
Background And Liquidity [Line Items]
Deferred offering costs			$ 6,412
IPO | Certain Selling Stockholders
Background And Liquidity [Line Items]
Issuance of common stock in public offering, net of issuance costs (in shares)			2,868,923

Basis of presentation (Details)

Basis of presentation (Details) - USD ($) $ in Thousands	Oct. 31, 2020	Jan. 31, 2020
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Lease liabilities (included in Current portion of debt and finance leases)	$ (3,018)
Current portion of debt and finance lease liabilities	4,722	$ 2,324
Lease liabilities, noncurrent (included in Long-term debt and finance leases)	(4,589)
Long term debt and finance lease liabilities	$ 24,439	21,540
Restatement Adjustment
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Lease liabilities (included in Current portion of debt and finance leases)		2,300
Current portion of debt and finance lease liabilities		2,300
Lease liabilities, noncurrent (included in Long-term debt and finance leases)		2,100
Long term debt and finance lease liabilities		$ 2,100

Summary of significant accoun_3

Summary of significant accounting policies (Details) - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2020		Feb. 01, 2020	Jan. 31, 2020	[1]
Concentration Risk [Line Items]
Lease right-of-use assets	$ 3,192	[1]	$ 2,741	$ 0
Operating lease liabilities	$ 3,446		$ 2,928
Accounts Receivable | Customer Concentration Risk | Customer One
Concentration Risk [Line Items]
Concentration risk, percentage	16.00%
Accounts Receivable | Customer Concentration Risk | Customer Two
Concentration Risk [Line Items]
Concentration risk, percentage	11.00%
[1]	Figures as of October 31, 2020 reflect the Company's February 1, 2020 adoption of Accounting Standards Codification No. 842, Leases (ASC 842) . For additional details, see Note 3(c), "Summary of significant accounting policies — Impact of recently adopted accounting pronouncements."

Composition of certain financ_3

Composition of certain financial statement captions - Schedule of Accrued Liabilities (Detail) - USD ($) $ in Thousands	Oct. 31, 2020	Jan. 31, 2020
Composition Of Certain Financial Statement [Abstract]
Payroll-related expenses and taxes	$ 7,846	$ 5,032
Payment processing fees liability	2,634	2,738
Other	2,182	1,473
Total	$ 12,662	$ 9,243

Composition of certain financ_4

Composition of certain financial statement captions - Schedule of Property and Equipment (Detail) - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2020	Jan. 31, 2020
Property, Plant and Equipment [Line Items]
Property and equipment	$ 61,825	$ 50,038
Less accumulated depreciation and amortization	(42,665)	(35,551)
Property and equipment — net	$ 19,160	14,487
PhreesiaPads and Arrivals Stations
Property, Plant and Equipment [Line Items]
Useful life (years)	3 years
Property and equipment	$ 29,857	26,389
Computer equipment
Property, Plant and Equipment [Line Items]
Useful life (years)	3 years
Property and equipment	$ 25,990	18,394
Computer software
Property, Plant and Equipment [Line Items]
Useful life (years)	3 years
Property and equipment	$ 3,010	2,297
Hardware development
Property, Plant and Equipment [Line Items]
Useful life (years)	3 years
Property and equipment	$ 1,024	1,024
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Useful life (years)	7 years
Property and equipment	$ 743	743
Leasehold improvements
Property, Plant and Equipment [Line Items]
Useful life (years)	2 years
Property and equipment	$ 1,201	$ 1,191

Composition of certain financ_5

Composition of certain financial statement captions - Additional Information (Detail) - USD ($)	Oct. 31, 2020	Jan. 31, 2020	Oct. 31, 2020	Oct. 31, 2019	Oct. 31, 2020	Oct. 31, 2019
Composition Of Certain Financial Statement [Line Items]
Depreciation			$ 2,447,000	$ 2,153,000	$ 7,125,000	$ 6,444,000
Finance lease, depreciation					2,278,000
Assets under finance lease	$ 17,078,000		17,078,000		17,078,000
Assets under finance lease, accumulated amortization	9,555,000		9,555,000		9,555,000
Capitalized cost of computer software			1,972,000	1,452,000	5,604,000	4,329,000
Capitalized computed software amortization			1,487,000	1,266,000	4,353,000	3,645,000
Capitalized computer software net	9,986,000	$ 8,735,000	9,986,000		9,986,000
Amortization of intangible assets			59,000	59,000	178,000	178,000
Changes in goodwill balance					0
Goodwill, impairment loss			0	0	0	0
Goodwill	250,000	$ 250,000	250,000		250,000
Capitalized implementation costs			283,000		434,000
Capitalized implementation costs, accumulated amortization	$ 13,000		13,000		13,000
Other income (expense)			62,000	$ 77,000	(229,000)	(740,000)
Loss on extinguishment of debt					$ 0	$ 1,073,000
Credit Concentration Risk | Accounts Receivable | Aged less than 30 days
Composition Of Certain Financial Statement [Line Items]
Concentration risk, percentage					58.00%
Credit Concentration Risk | Accounts Receivable | Aged over 90 days
Composition Of Certain Financial Statement [Line Items]
Concentration risk, percentage					15.00%
Acquired technology
Composition Of Certain Financial Statement [Line Items]
Finite-lived intangible assets, remaining amortization period	3 years 1 month 6 days	3 years 10 months 24 days
Customer relationship
Composition Of Certain Financial Statement [Line Items]
Finite-lived intangible assets, remaining amortization period	5 years 1 month 6 days	5 years 10 months 24 days
Computer equipment
Composition Of Certain Financial Statement [Line Items]
Assets under finance lease	$ 17,078,000	$ 12,283,000	17,078,000		$ 17,078,000
Assets under finance lease, accumulated amortization	$ 9,555,000	$ 7,724,000	$ 9,555,000		$ 9,555,000

Composition of certain financ_6

Composition of certain financial statement captions - Schedule Of Finite Lived Intangible Assets (Detail) - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2020	Jan. 31, 2020
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangibles	$ 1,470	$ 1,470
Less accumulated amortization	(450)	(271)
Net carrying value	$ 1,020	1,199
Acquired technology
Finite-Lived Intangible Assets [Line Items]
Useful life (years)	5 years
Finite-lived intangibles	$ 490	490
Customer relationship
Finite-Lived Intangible Assets [Line Items]
Useful life (years)	7 years
Finite-lived intangibles	$ 980	$ 980

Composition of certain financ_7

Composition of certain financial statement captions - Schedule of Finite Lived Intangible Assets Future Amortization Expense (Detail) - USD ($) $ in Thousands	Oct. 31, 2020	Jan. 31, 2020
Composition Of Certain Financial Statement [Abstract]
2021 (Remaining three months)	$ 60
2022	238
2023	238
2024	224
2025 - thereafter	260
Net carrying value	$ 1,020	$ 1,199

Composition of certain financ_8

Composition of certain financial statement captions - Schedule Of Accounts Notes Loans And Financing Receivable (Detail) - USD ($) $ in Thousands	Oct. 31, 2020	Jan. 31, 2020
Composition Of Certain Financial Statement [Abstract]
Billed	$ 26,000	$ 22,245
Unbilled	2,344	676
Total accounts receivable, gross	28,344	22,921
Less accounts receivable allowances	(750)	(943)
Total accounts receivable	$ 27,594	$ 21,978

Composition of certain financ_9

Composition of certain financial statement captions - Schedule of Allowance for Credit Losses (Details) $ in Thousands	9 Months Ended
	Oct. 31, 2020USD ($)
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Balance, January 31, 2020	$ 943
Bad debt expense	396
Write-offs and adjustments	(589)
Balance, October 31, 2020	$ 750

Composition of certain finan_10

Composition of certain financial statement captions - Schedule of Prepaids and Other Current Assets (Details) - USD ($) $ in Thousands	Oct. 31, 2020	Jan. 31, 2020
Composition Of Certain Financial Statement [Abstract]
Prepaid software and business systems	$ 1,994	$ 1,611
Prepaid PhreesiaPads	394	645
Prepaid data center expenses	350	751
Prepaid insurance	1,969	1,259
Other prepaid expenses and other current assets	2,118	891
Total prepaid and other current assets	$ 6,825	$ 5,157

Revenue - Additional Informatio

Revenue - Additional Information (Detail) - USD ($)	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Oct. 31, 2019	Oct. 31, 2020	Oct. 31, 2019
Revenue From Contract With Customer [Line Items]
Capitalized contract cost, amortization period	3 years		3 years
Capitalized contract cost, amortization	$ 505,000	$ 491,000	$ 2,280,000	$ 1,465,000
Capitalized contract cost, impairment loss	0	0	0	0
Subscription and Related Services
Revenue From Contract With Customer [Line Items]
Lease income	$ 1,593,000	$ 1,496,000	$ 4,732,000	$ 4,462,000

Revenue - Schedule Of Rollforwa

Revenue - Schedule Of Rollforward of contract assets and contract liabilities (Detail) $ in Thousands	9 Months Ended
	Oct. 31, 2020USD ($)
Contract With Customer Asset [Roll Forward]
Beginning balance - Contract assets (unbilled accounts receivable)	$ 676
Amount transferred to receivables from beginning balance of contract assets	(676)
Contract asset additions, net of reclassification to receivables	2,344
Ending balance - Contract assets (unbilled accounts receivable)	2,344
Contract With Customer Liability [Roll Forward]
Beginning balance - Contract liabilities (deferred revenue)	5,401
Revenue recognized that was included in deferred revenue at the beginning of the period	(5,004)
Revenue recognized that was not included in deferred revenue at the beginning of the period	(1,168)
Increases due to invoicing prior to satisfaction of performance obligations	7,394
Ending balance - Contract liabilities (deferred revenue)	$ 6,623

Revenue - Schedule Of Deferred

Revenue - Schedule Of Deferred contract acquisition costs (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Oct. 31, 2019	Oct. 31, 2020	Oct. 31, 2019	Oct. 31, 2020	Jan. 31, 2020
Capitalized Contract Cost [Roll Forward]
Beginning balance, January 31, 2020			$ 3,314
Additions to deferred contract acquisition costs			1,901
Amortization of deferred contract acquisition costs	$ (505)	$ (491)	(2,280)	$ (1,465)
Ending balance, October 31, 2020	2,935		2,935
Deferred contract acquisition costs, current (to be amortized in next 12 months)					$ 1,708	$ 1,720
Deferred contract acquisition costs, non-current					1,227	1,594
Total deferred contract acquisition costs	$ 2,935		$ 2,935		$ 2,935	$ 3,314

Debt and Finance Lease Liabil_3

Debt and Finance Lease Liabilities - Schedule Of Outstanding loan balances (Detail) - USD ($) $ in Thousands	Oct. 31, 2020	Jan. 31, 2020
Debt Instrument [Line Items]
Finance leases	$ 7,607	$ 3,612
Other debt	2,146	808
Accrued interest and payments	65	381
Total debt and finance lease liabilities, before original issue discount	30,481	24,801
Less deferred financing costs and original issue discount	(1,320)	(937)
Debt and finance lease liabilities	29,161	23,864
Less - current portion of debt and finance lease liabilities	(4,722)	(2,324)
Long term debt and finance lease liabilities	24,439	21,540
Revolving credit facility
Debt Instrument [Line Items]
Long term debt	20,663	0
Term loan
Debt Instrument [Line Items]
Long term debt	$ 0	$ 20,000

Debt and Finance Lease Liabil_4

Debt and Finance Lease Liabilities - Second Amended and Restated Loan and Security Agreement (Details) - USD ($)	May 05, 2020	Feb. 28, 2019	Oct. 31, 2020	Jul. 31, 2020	Oct. 31, 2020	Oct. 31, 2019	Jan. 31, 2020
Debt Instrument [Line Items]
Debt prepayment fee					$ 0	$ 300,000
Payment of accrued final payment fee					225,000	0
Revolving credit facility
Debt Instrument [Line Items]
Long term debt			$ 20,663,000		20,663,000		$ 0
Second Amended And Restated Loan And Security Agreement
Debt Instrument [Line Items]
Effective interest rate			4.50%
Remaining borrowing capacity			$ 29,337,000		$ 29,337,000
Second Amended And Restated Loan And Security Agreement | Revolving credit facility
Debt Instrument [Line Items]
Maximum borrowing capacity	$ 50,000,000
Long term debt	20,663,000
Debt instrument, term					5 years
Annual fee amount	125,000
Payment of debt fees				$ 125,000
Termination fee	187,000
Monthly termination fee decrease	$ 6,000
Termination fee percentage before year two	0.015
Termination fee percentage before year three	0.0075
Termination fee percentage before year four	0.005
Debt issuance costs			531,000
Entrance fee			$ 125,000
Second Amended And Restated Loan And Security Agreement | Revolving credit facility | Before EBITDA Benchmark
Debt Instrument [Line Items]
Stated interest rate	4.50%
Second Amended And Restated Loan And Security Agreement | Revolving credit facility | After EBITDA Benchmark
Debt Instrument [Line Items]
Stated interest rate			4.00%		4.00%
Second Amended And Restated Loan And Security Agreement | Revolving credit facility | Prime Rate | After EBITDA Benchmark
Debt Instrument [Line Items]
Variable interest rate					(0.50%)
Second Amended And Restated Loan And Security Agreement, Optional Capacity Increase | Revolving credit facility
Debt Instrument [Line Items]
Maximum borrowing capacity	$ 65,000,000
Term loan | Revolving credit facility
Debt Instrument [Line Items]
Repayments of debt	20,000,000
Debt prepayment fee						$ 300,000
Payment of accrued final payment fee					$ 363,000
Amended And Restated Loan And Security Agreement | Prime Rate
Debt Instrument [Line Items]
Variable interest rate		1.50%
Amended And Restated Loan And Security Agreement | Revolving credit facility
Debt Instrument [Line Items]
Maximum borrowing capacity		$ 25,000,000
Long term debt	$ 0						$ 0
Debt prepayment fee			$ 406,000

Debt and Finance Lease Liabil_5

Debt and Finance Lease Liabilities - First Amended and Restated Loan and Security Agreement (Details) - USD ($)	Feb. 28, 2019	Oct. 31, 2020	Oct. 31, 2019	Oct. 31, 2020	Oct. 31, 2019	May 05, 2020	Jan. 31, 2020
Debt Instrument [Line Items]
Line of credit, facility fees		$ 100,000	$ 100,000
Loss on extinguishment of debt				$ 0	$ 1,073,000
Common Stock
Debt Instrument [Line Items]
Exercise price (in dollars per share)		$ 8.02		$ 8.02			$ 8.02
Warrants outstanding (in shares)		75,137		75,137			75,137
Revolving credit facility
Debt Instrument [Line Items]
Long term debt		$ 20,663,000		$ 20,663,000			$ 0
Loans Payable
Debt Instrument [Line Items]
Loss on extinguishment of debt					$ 1,073,000
Term loan
Debt Instrument [Line Items]
Debt instrument, face amount	$ 20,000,000
Amended And Restated Loan And Security Agreement
Debt Instrument [Line Items]
Interest expense			$ 257,000
Number of securities called by warrants (in shares)	150,274
Exercise price (in dollars per share)	$ 8.02
Amended And Restated Loan And Security Agreement | Prime Rate
Debt Instrument [Line Items]
Variable interest rate	1.50%
Amended And Restated Loan And Security Agreement | Revolving credit facility
Debt Instrument [Line Items]
Maximum borrowing capacity	$ 25,000,000
Long term debt						$ 0	$ 0

Debt and Finance Lease Liabil_6

Debt and Finance Lease Liabilities - Other Debt (Details)	Jul. 21, 2020USD ($)installment	Apr. 10, 2020USD ($)	Nov. 02, 2018USD ($)installment	Oct. 31, 2020USD ($)
Debt Instrument [Line Items]
Number of installment payments | installment			4
Insurance Premium Financing Agreement
Debt Instrument [Line Items]
Long term debt				$ 1,341,000
Stated interest rate	2.60%
Number of installment payments | installment	2
Installment payment, amount	$ 677,000
Total interest cost	$ 13,000
Vendor Financing Agreement Maturing May 2023
Debt Instrument [Line Items]
Long term debt				132,000
Stated interest rate		2.94%
Installment payment, amount		$ 46,000
Debt instrument, face amount		$ 174,000
Vendor Financing Agreement Maturing June 2022
Debt Instrument [Line Items]
Long term debt				$ 673,000
Stated interest rate			9.83%
Installment payment, amount			$ 183,000
Debt instrument, face amount			$ 1,256,000

Debt and Finance Lease Liabil_7

Debt and Finance Lease Liabilities - Schedule of long-term debt maturities (Detail) - USD ($) $ in Thousands	Oct. 31, 2020	Jan. 31, 2020
Total
Fiscal 2021 (remaining three months)	$ 1,509
2022	4,050
2023	2,442
2024	1,290
2025	21,190
Total debt and finance lease liabilities, before original issue discount	30,481	$ 24,801
Debt
Fiscal 2021 (remaining three months)	845
2022	1,077
2023	184
2024	40
2025	20,728
Total Long-Term Debt Maturities	22,874
Finance Leases
Fiscal 2021 (remaining three months)	664
2022	2,973
2023	2,258
2024	1,250
2025	462
Total finance lease liabilities	$ 7,607	$ 3,612

Debt and Finance Lease Liabil_8

Debt and Finance Lease Liabilities - Additional information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Oct. 31, 2019	Oct. 31, 2020	Oct. 31, 2019
Debt Disclosure [Abstract]
Interest expense, net	$ 467	$ 219	$ 1,206	$ 1,769
Amortization of debt discount	74	147	318	412
Interest expense	471	557	1,305	2,142
Interest income	$ 5	$ 338	$ 99	$ 373

Stockholders' Equity (Detail)

Stockholders' Equity (Detail) - USD ($) $ / shares in Units, $ in Thousands	Oct. 23, 2020	Oct. 31, 2020	Oct. 31, 2019	Jul. 31, 2019	Jan. 31, 2020	Jul. 22, 2019
Equity [Abstract]
Common stock, shares authorized (in shares)		500,000,000			500,000,000	500,000,000
Common stock, par value per share (in dollars per share)		$ 0.01			$ 0.01	$ 0.01
Issuance of common stock in public offering, net of issuance costs (in shares)	5,750,000
Issue price per share (in dollars per share)	$ 32
Issuance of common stock in public offering, net of issuance costs	$ 174,800	$ 174,510		$ 124,698
Issuance of common stock, issuance costs	$ 290	$ 290	$ 56	$ 6,084
Preferred stock, shares authorized (in shares)						20,000,000
Preferred stock, par value (in dollars per share)						$ 0.01
Preferred stock, shares issued (in shares)		0			0
Preferred stock, shares outstanding (in shares)		0			0

Equity-based compensation - Add

Equity-based compensation - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Oct. 31, 2019	Oct. 31, 2020	Oct. 31, 2019	Jun. 30, 2019	Jan. 31, 2018	Dec. 31, 2006
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Intrinsic value	$ 52,537	$ 1,728
Unrecognized compensation cost, stock options	4,078		$ 4,078
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	632	809	$ 2,111	$ 2,051
Weighted average remaining expense term			2 years 21 days
Incremental expense	$ 88		$ 312
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant (in shares)	855,873		855,873
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum term			7 years
Vesting term			4 years
Stock-based compensation expense	$ 2,684	957	$ 7,505	1,781
Weighted average remaining expense term			3 years 2 months 12 days
RSU's granted (in shares)	126,198		701,392
Unrecognised compensation costs	$ 33,424		$ 33,424
Restricted Stock Units (RSUs) | Vital Score Inc
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	8	$ 10	25	$ 30
Unrecognised compensation costs	$ 66		$ 66
Restricted Stock Units (RSUs) | Share-based Payment Arrangement, Year 1
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of vest option			10.00%
Restricted Stock Units (RSUs) | Share-based Payment Arrangement, Year 2
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of vest option			20.00%
Restricted Stock Units (RSUs) | Share-based Payment Arrangement, Year 3
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of vest option			30.00%
Restricted Stock Units (RSUs) | Share-based Payment Arrangement, Year 4
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of vest option			40.00%
2006 Stock Option Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for issuance (in shares)							4,424,986
2018 Stock Option Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for issuance (in shares)						3,048,490
2019 Stock Option and Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserve for future issuance (in shares)					2,139,683
Percentage increase in number of shares reserved			5.00%
Number of shares available for grant (in shares)	4,181,522		4,181,522
2019 Stock Option and Incentive Plan | Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum term			10 years
Vesting term			4 years
Percentage of vest option			25.00%

Equity-based compensation - Sto

Equity-based compensation - Stock Option Activity (Detail) - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended
	Oct. 31, 2020
Number of options
Number of options outstanding, beginning (in shares)	5,516,452
Granted (in shares)	0
Exercised (in shares)	(1,610,207)
Forfeited and expired (in shares)	(54,083)
Number of options outstanding, ending (in shares)	3,852,162
Exercisable (in shares)	2,625,365
Amount vested at the beginning of the period (in shares)	476,680
Weighted- average exercise price
Weighted- average exercise price outstanding, beginning balance (in dollars per share)	$ 3.80
Granted (in dollars per share)	0
Exercised (in dollars per share)	2.08
Forfeited and expired (in dollars per share)	7.31
Weighted- average exercise price outstanding, ending balance (in dollars per share)	4.46
Exercisable (in dollars per share)	3.12
Amount vested at the end of the period (in dollars per share)	$ 5.52
Outstanding and expected to vest- end of the period	6 years 10 days
Exercisable- end of period	5 years 1 month 2 days
Aggregate intrinsic value outstanding and expected to vest	$ 125,217
Aggregate intrinsic value exercisable	$ 88,856

Equity-based compensation - Res

Equity-based compensation - Restricted stock Units (Detail) - Restricted Stock Units (RSUs) - shares	3 Months Ended	9 Months Ended
	Oct. 31, 2020	Oct. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Beginning balance (in shares)		1,447,418
Granted (in shares)	126,198	701,392
Vested (in shares)		(76,915)
Forfeited (in shares)		(93,915)
Ending balance (in shares)	1,977,980	1,977,980

Stock warrants (Details)

Stock warrants (Details) - Common Stock - $ / shares	Nov. 06, 2020	Oct. 31, 2020	Jan. 31, 2020
Class of Warrant or Right [Line Items]
Warrants outstanding (in shares)		75,137	75,137
Exercise price (in dollars per share)		$ 8.02	$ 8.02
Subsequent Event
Class of Warrant or Right [Line Items]
Warrants exercised (in shares)	75,137
Shares issued upon conversion of warrants (in shares)	60,388

Fair value measurements - Summa

Fair value measurements - Summary of Fair Value Hierarchy (Details) - Fair Value, Recurring - USD ($) $ in Thousands	Oct. 31, 2020	Jan. 31, 2020
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Money market mutual funds	$ 237,499	$ 86,600
Foreign currency derivative contracts	34	58
Total assets	237,533	86,658
Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Money market mutual funds	237,499	86,600
Foreign currency derivative contracts	0	0
Total assets	237,499	86,600
Significant Other Observable Inputs (Level 2)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Money market mutual funds	0	0
Foreign currency derivative contracts	34	58
Total assets	34	58
Significant Unobservable Inputs (Level 3)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Money market mutual funds	0	0
Foreign currency derivative contracts	0	0
Total assets	$ 0	$ 0

Fair value measurements - Narra

Fair value measurements - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Oct. 31, 2019	Oct. 31, 2020	Oct. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Gain (loss) on foreign currency derivative instruments not designated as hedging instruments	$ 59	$ 327	$ (250)	$ 256

Leases - Additional Information

Leases - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended
	Oct. 31, 2020		Oct. 31, 2019	Oct. 31, 2020		Oct. 31, 2019	Feb. 01, 2020	Jan. 31, 2020	[1]
Lessee, Lease, Description [Line Items]
Operating lease, weighted average remaining lease term	2 years 8 months 12 days			2 years 8 months 12 days
Operating lease, weighted average discount rate	3.50%			3.50%
Finance lease, weighted average remaining lease term	2 years 9 months 18 days			2 years 9 months 18 days
Finance lease, weighted average discount rate	4.90%			4.90%
Lease right-of-use assets	$ 3,192	[1]		$ 3,192	[1]		$ 2,741	$ 0
Operating cash used for operating leases				1,234
Subscription and Related Services
Lessee, Lease, Description [Line Items]
Lease income	$ 1,593		$ 1,496	$ 4,732		$ 4,462
Minimum | Computer equipment
Lessee, Lease, Description [Line Items]
Finance lease, term of contract	2 years			2 years
Maximum | Computer equipment
Lessee, Lease, Description [Line Items]
Finance lease, term of contract	3 years			3 years
[1]	Figures as of October 31, 2020 reflect the Company's February 1, 2020 adoption of Accounting Standards Codification No. 842, Leases (ASC 842) . For additional details, see Note 3(c), "Summary of significant accounting policies — Impact of recently adopted accounting pronouncements."

Leases - Supplemental Balance S

Leases - Supplemental Balance Sheet Information (Details) - USD ($) $ in Thousands		Oct. 31, 2020		Feb. 01, 2020	Jan. 31, 2020
Leases [Abstract]
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]		us-gaap:PropertyPlantAndEquipmentNet
Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]		us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]		us-gaap:LongTermDebtAndCapitalLeaseObligations
Operating leases:
Lease right-of-use assets		$ 3,192	[1]	$ 2,741	$ 0	[1]
Lease liabilities, current	[1]	1,288			0
Lease liabilities, noncurrent	[1]	2,158			0
Total operating lease liabilities		3,446		$ 2,928
Finance leases:
Property and equipment, at cost		17,078
Accumulated depreciation		(9,555)
Property and equipment, net		7,523
Lease liabilities (included in Current portion of debt and finance leases)		3,018
Lease liabilities, noncurrent (included in Long-term debt and finance leases)		4,589
Total finance lease liabilities		$ 7,607			$ 3,612
[1]	Figures as of October 31, 2020 reflect the Company's February 1, 2020 adoption of Accounting Standards Codification No. 842, Leases (ASC 842) . For additional details, see Note 3(c), "Summary of significant accounting policies — Impact of recently adopted accounting pronouncements."

Leases - Lease Expense (Details

Leases - Lease Expense (Details) $ in Thousands	9 Months Ended
	Oct. 31, 2020USD ($)
Operating leases:
Operating lease cost	$ 1,300
Variable lease cost	191
Total operating lease cost	1,491
Finance leases:
Amortization of right-of-use assets	2,278
Interest on lease liabilities	236
Total finance lease cost	$ 2,514

Leases - Lease Liability Maturi

Leases - Lease Liability Maturity Schedule (Details) - USD ($) $ in Thousands	Oct. 31, 2020	Feb. 01, 2020	Jan. 31, 2020
Operating
Fiscal 2021 (remaining three months)	$ 434
2022	1,228
2023	1,142
2024	758
2025	52
Total future minimum lease payments	3,614
Less: interest	(168)
Present value of lease liabilities	3,446	$ 2,928
Finance Leases
Fiscal 2021 (remaining three months)	850
2022	3,139
2023	2,352
2024	1,290
2025	472
Total future minimum lease payments	8,103
Less: interest	(496)
Present value of lease liabilities	$ 7,607		$ 3,612

Leases - Maturity Under Previou

Leases - Maturity Under Previous Guidance (Details) $ in Thousands	Jan. 31, 2020USD ($)
Leases [Abstract]
2021	$ 1,824
2022	819
2023	464
2024	277
Total	$ 3,384

Leases - Supplemental Cash Flow

Leases - Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands		9 Months Ended
		Oct. 31, 2020	Oct. 31, 2019
Leases [Abstract]
Operating cash used for operating leases		$ 1,234
Operating cash used for finance leases		236
Financing cash used for finance leases		1,797	$ 1,624
Total		3,267
Right-of-use assets recorded in exchange for lease liabilities	[1]	4,420	$ 0
Right-of-use asset obtained in exchange for finance lease liabilities		6,050
Right-of-use asset obtained in exchange for lease liabilities		$ 10,470
[1]	Includes $2,741 initial right of use asset recorded upon adoption of ASC 842.

Income taxes (Detail)

Income taxes (Detail) - USD ($)	3 Months Ended		9 Months Ended
	Oct. 31, 2020	Oct. 31, 2019	Oct. 31, 2020	Oct. 31, 2019
Income Tax Disclosure [Abstract]
Provision for income taxes	$ (194,000)	$ (64,000)	$ (371,000)	$ (183,000)
Effective tax rate			2.00%	1.10%

Net loss per share attributab_3

Net loss per share attributable to common stockholders - Schedule of earnings per share basic and diluted (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended						9 Months Ended
	Oct. 31, 2020	Jul. 31, 2020	Apr. 30, 2020	Oct. 31, 2019	Jul. 31, 2019	Apr. 30, 2019	Oct. 31, 2020	Oct. 31, 2019
Numerator:
Net loss	$ (6,713)	$ (6,371)	$ (6,112)	$ (2,437)	$ (7,493)	$ (6,695)	$ (19,196)	$ (16,625)
Preferred stock dividend paid	0			0			0	(14,955)
Accretion of redeemable convertible preferred stock to redemption value	0			0			0	(56,175)
Net loss attributable to common stockholders	$ (6,713)			$ (2,437)			$ (19,196)	$ (87,755)
Denominator:
Weighted-average shares of common stock outstanding, basic and diluted (in shares)	38,511,370			35,790,951			37,855,503	15,007,247
Net loss per share attributable to common stockholders, basic and diluted (in dollars per share)	$ (0.17)			$ (0.07)			$ (0.51)	$ (5.85)

Net loss per share attributab_4

Net loss per share attributable to common stockholders - Schedule of antidilutive securities excluded from computation of earnings per share (Detail) - shares	9 Months Ended
	Oct. 31, 2020	Oct. 31, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	5,905,279	6,873,284
Stock options to purchase common stock and restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	5,830,142	6,645,106
Warrants to purchase common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	75,137	228,178

Related party transactions (Det

Related party transactions (Detail) - Affiliated Entity - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Oct. 31, 2019	Oct. 31, 2020	Oct. 31, 2019	Jan. 31, 2020
Related Party Transaction [Line Items]
Recognized revenue	$ 1,223	$ 2,425	$ 4,098
Accounts receivable				$ 2,072